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Autophagy is a cellular catabolic process critical for cell viability and homeostasis. As 
a membrane trafficking pathway, it is closely related to endocytosis and shares many 
points of convergence with endocytosis. In the first part of this dissertation, I find that 
although the two pathways are closely related, autophagosome fusion with lysosomes 
is governed by a distinct molecular mechanism from endosomal fusion with 
lysosomes. 
 
In recent years, the discovery of autophagy-essential-genes has accelerated research 
into the molecular mechanisms governing autophagy. For example, inhibition of 
mammalian target of rapamycin (mTOR) complex-1 (mTORC1) activates autophagy 
by relieving its inhibitory effects on autophagy essential gene, ULK1- a mTORC1 
substrate whose dephosphorylation is required for autophagy induction.   
 
Puzzlingly, I observe that amino acid starvation triggers more rapid autophagy than 
pharmacological inhibition of mTORC1, although they both block mTORC1 activity 
with similar kinetics. Here I find that in addition to mTORC1 inactivation, starvation 
also causes a stimulation in phosphatase activity toward ULK1. In the second part of 
this dissertation, I identify the starvation-stimulated phosphatase for ULK1 as the 
!PP2A-B55α complex and attempt to elucidate the mechanism of phosphatase 
stimulation during starvation.  
 
I find that treatment of cells with starvation but not mTORC1 inhibitors triggers 
dissociation of PP2A from its inhibitor Alpha4. Furthermore, pancreatic ductal 
adenocarcinoma cells (PDACs), whose growth depends on high basal autophagy, 
possess stronger basal phosphatase activity toward ULK1 and require ULK1 for 
sustained anchorage-independent growth. Taken together, these results suggest that 
concurrent mTORC1 inactivation and PP2A-B55α stimulation fuel ULK1-dependent 
autophagy.  
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CHAPTER 1. INTRODUCTION 
 
1.1 Autophagy: A lysosomal degradative pathway 
Autophagy is a conserved catabolic process that utilizes lysosomal activity to turnover 
cellular proteins and organelles. Mammalian cells can undergo three types of 
autophagy: macroautophagy, microautophagy and chaperone-mediated autophagy. 
These modes of autophagy differ in the type of cargo to be degraded and the methods 
of delivering them to lysosomes. Chaperone-mediated autophagy makes use of a 
protein translocation pathway that selectively feeds individual substrate proteins 
directly into the lysosome. Microautophagy occurs through direct sequestration of 
cargo involving the formation of tubular invaginations at the lysosomal membrane. 
Macroautophagy delivers cargo to the lysosomes through the formation and transport 
of specific intracellular membrane vesicles termed autophagosomes (Chen and 
Klionsky, 2011; Mizushima and Komatsu, 2011; Todde et al., 2009). 
 
Of the three types of autophagy, macroautophagy is thought to occur predominantly 
and is the most well-studied (Mizushima and Komatsu, 2011). The process of 
macroautophagy, herein referred to as autophagy, starts with the formation of a cup-
shaped membrane structure, termed the phagophore or isolation membrane. The 
phagophore elongates, sequesters cytosolic components (cargo), and eventually seals 
to form a double-membraned vesicle called the autophagosome. Cargo loading into 
autophagosomes may be selective for specific proteins, organelles or pathogens 
through the use of adaptors such as Atg32 (Kanki et al., 2009) in yeast, and 
SQSTM1/p62 (Pankiv et al., 2007), NBR1 (Kirkin et al., 2009), and NCOA4 (Mancias 
et al., 2014) in mammalian cells, or non-specifically through bulk loading of 
cytoplasmic contents (Mizushima et al., 2011). Autophagosomes fuse with lysosomes, 
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resulting in cargo degradation and concomitant release of the metabolic byproducts 
such as amino acids and other molecules through permeases in the lysosomal 
membrane. As a membrane trafficking pathway, autophagy shares several points of 
convergence with endocytosis, although these converging points, such as lysosomal 
fusion, can be differentially regulated in autophagy and endocytosis (Ganley et al., 
2011). The turnover of long-lived, aggregated or damaged proteins and organelles by 
autophagy is essential for maintaining cellular homeostasis. While autophagy occurs at 
basal levels under normal conditions, it is activated in response to cellular stresses 
such as nutrient starvation, hypoxia, growth factor withdrawal, ER stress and pathogen 
infection. Upon these stresses, the cell employs autophagy either to re-deploy its 
resources to tide over the period of stress or to degrade harmful components (such as 
damaged mitochondria or invading pathogens) via lysosomal degradation (Kroemer et 
al., 2010). Dysregulation of autophagy has been implicated in a range of diseases 
including neurodegenerative disorders most typically involving the accumulation of 
pathogenic proteins, inflammatory disorders such as Crohn’s Disease, and cancer 
(Kimmelman, 2011; Wong et al., 2011).  
 
Molecular players in the autophagy pathway  
The study of autophagy has accelerated in the last decade because of the discovery of 
autophagy related (Atg) genes by yeast genetics (Harding et al., 1995; Thumm et al., 
1994; Tsukada and Ohsumi, 1993) and subsequently, their mammalian homologues 
(Mizushima et al., 2011; Yang and Klionsky, 2010a). Up to 36 Atg genes have been 
identified through genetic screens, and the Atg genes making up the core machinery of 
autophagy can be classified into several functional units: the Atg1/ULK1 complex, 
commonly considered as an initiator in the autophagic cascade, the VPS34 
phosphatidylinositol 3-kinase (PI3K) complex, two ubiquitin-like conjugation systems 
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(Atg5-12, Atg8/LC3-PE), PI3P effector Atg2-Atg18 complex and the transmembrane 
protein Atg9. Our laboratory focuses on the Atg1/ULK1 initiator complex, because of 
its important role as a bridge between nutrient sensing and induction of an autophagic 
response both in yeast and mammalian cells.  
 
1.2 ULK1: an autophagy essential gene 
In yeast, Atg1 was originally identified from genetic screens. Through these studies, 
multiple complementation groups affecting both autophagosome accumulation 
(Thumm et al., 1994; Tsukada and Ohsumi, 1993) and cytoplasm-to-vacuole targeting 
(Cvt) (Harding et al., 1995) were found. Atg1 mutants failed to accumulate autophagic 
bodies in the presence of the protease inhibitor PMSF and died at a faster rate during 
nutrient starvation, linking autophagy and Atg1 with cellular metabolism (Tsukada 
and Ohsumi, 1993). Atg1 is a serine-threonine Kinase and the only protein kinase 
among the 36 Atg genes described so far.  
 
Atg1 shares strong homology with C. elegans uncoordinated-51 (UNC-51) (Matsuura 
et al., 1997), which has two mammalian homologs known as Unc-51 like kinase-1 
(ULK1) and ULK2 (Figure 1.1) (Kuroyanagi et al., 1998; Yan et al., 1999). ULK1 
was independently identified as an essential component for starvation-induced 
autophagy in an RNAi-based screen by Tooze and colleagues to identify protein 
kinases involved in mammalian autophagy (Chan et al., 2007). Subsequent 
mechanistic analysis confirmed that ULK1 is indeed the functional equivalent of yeast 
Atg1 (Young et al., 2006), and functions in a complex containing ATG13, FIP200 and 
ATG101 to mediate signaling from mTORC1 (Ganley et al., 2009; Hara et al., 2008; 
Hosokawa et al., 2009; Jung et al., 2009).  
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ULK1 and ULK2 are very similar in sequence (55% overall sequence identity), and 
have redundant roles in autophagy (Lee and Tournier, 2011; Yan et al., 1999). This is 
best supported by genetic studies in mice. Right after birth, neonate mice face a brief 
period of severe starvation during which autophagy is essential for survival. While 
Ulk1 and Ulk2 double knockout mice display the same perinatal-lethal phenotype as 
mice lacking core autophagy genes such as Atg5 or Atg7 (Cheong et al., 2011; 
Komatsu et al., 2005; Kuma et al., 2004), Ulk1-/- mice have a relatively mild 
phenotype of delayed reticulocyte maturation (Kundu et al., 2008), indicating that 
Ulk2 can at least partially compensate for the loss of Ulk1. Mechanistically, both 
ULK1 and ULK2 have been shown to be recruited to isolation membranes upon 
autophagy induction, both are able to bind to the regulatory proteins ATG13 and 
FIP200 (Figure 1.2), and both their kinase-dead mutants have dominant negative 
properties (blocks autophagy) when overexpressed in cells (Chan et al., 2009; Hara et 
al., 2008; Jung et al., 2009).  
 
In addition to the N-terminal kinase domains, ULK1 and ULK2 share significant 
homology in their C terminal regions (Figure 1.1), suggesting that it may have a role 
in autophagy. Domain studies of ULK1 have shown that its C terminal domain (CTD) 
is required both for interaction with ATG13 and FIP200 and for translocation of 
ULK1 to isolation membranes (Chan et al., 2007; Chan et al., 2009; Hara et al., 2008).  
Mammals have three additional protein kinases that are homologous to the kinase 
domains of ULK1 and ULK2. They are ULK3, ULK4 and STK36 (also known as 
“fused”) (Figure 1.1). These additional ULKs do not have the conserved C terminal 
sequence and are not thought to be involved in starvation-induced autophagy. It is 
however, possible that they may play a role in other forms of autophagy. In support of 
this, ULK3 was linked to autophagy induction during senescence (Young et al., 2009). 
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1.3 The ULK1 complex: integrating signals from nutrient sensors 
Previous work in both yeast and mammalian systems suggest that the ULK1 complex 
senses upstream signals, particularly the nutrient and energy signals, mainly via 
changes in its phosphorylation status. Both ULK1 and ATG13 are hyper-
phosphorylated in nutrient-rich conditions and undergo global dephosphorylation upon 
starvation. At least 30 phosphorylation sites have been detected by mass spectometry 
on ULK1, although the majority of the responsible kinases and the functions of these 
phosphorylation events remain to be identified (Mack et al., 2012). 
 
As a major nutrient/energy sensor, mTOR has been reported to directly phosphorylate 
ULK1 and ATG13. The mTOR complex 1 (mTORC1), consisting of mTOR, Raptor 
and mLST8, is responsive to growth factors and amino acid levels and has been shown 
Figure 1.1 Schematic representations of Atg1 and its homologous proteins in 
different organisms. A representation of Atg1 (yeast), UNC-51 (C. elegans) and 
the ULK family (mice) is shown. High sequence similarity is observed mainly in 
the kinase domains. Significant similarity is also seen in the C-terminal of Atg1, 
UNC-51, ULK1 and ULK2, defining a C-terminal domain (CTD) of 150-250 amino 
acids. The overall sequence identity to mouse ULK1 as calculated by ClustalW is 
shown on the left. 
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to phosphorylate both ULK1 and ATG13 (Ganley et al., 2009; Hosokawa et al., 2009; 
Jung et al., 2009). The mTORC1 complex binds to ULK1 directly through Raptor 
under nutrient-rich conditions and dissociates from the ULK1 complex upon 
starvation (Hosokawa et al., 2009; Lee et al., 2010). mTORC1-driven ULK1 
phosphorylation correlates with autophagy inhibition and weaker ULK1 kinase 
activity (Ganley et al., 2009; Hosokawa et al., 2009; Jung et al., 2009). It is unclear if 
mTORC1 exerts its inhibitory effects simply by affecting the kinase activity of ULK1. 
Alternatively, mTORC1 phosphorylation events may influence the localization of the 
ULK1 complex and exert its inhibitory effects by sequestering or physically separating 
the ULK1 complex from its enzymatic substrates. 
 
It has been known for some time that another important cellular energy sensor, 
AMPK, can play a role in autophagy induction by phosphorylating TSC2 and Raptor 
to inactivate mTORC1, hence indirectly activating the ULK1 complex. Recently, 
AMPK has also been shown to directly interact with and phosphorylate ULK1 in a 
nutrient-dependent manner (Egan et al., 2011; Kim et al., 2011; Lee et al., 2010; 
Shang et al., 2011) (Figure 1.2). Phosphorylation sites on ULK1 have been mapped by 
several groups and in some cases attributed to either mTORC1 or AMPK, but with 
very few overlapping sites between the groups (Dorsey et al., 2009; Egan et al., 2011; 
Kim et al., 2011; Shang et al., 2011). Among the phosphorylation sites reported, 
Ser555, Ser637 and Ser757 were reported by three or more independent groups 
(Figure 1.2). AMPK phosphorylation site Ser555 is thought to recruit phospho-binding 
protein 14-3-3 to the ULK1 complex (Egan et al., 2011; Lee et al., 2010; Mack et al., 
2012). mTORC1 site Ser757 is required for AMPK binding as its mutation disrupts 
ULK1-AMPK interaction (Kim et al., 2011; Shang et al., 2011). The effect of AMPK 
phosphorylation on the ULK1 complex and autophagy are not well established, with 
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conflicting reports on whether it leads to stimulation or inhibition of autophagy. The 
study by Guan and colleagues (Kim et al., 2011) suggests that phosphorylation of 
AMPK sites on ULK1 are stimulated by glucose starvation, and contribute to ULK1 
activation. In this case, ULK1 kinase activity (measured by ULK1 
autophosphorylation) increased upon glucose starvation and was correlated with 
AMPK activation. However, the study by Shang et al. (Shang et al., 2011) identified 
AMPK sites that were dephosphorylated upon amino acid starvation; phospho-mutants 
defective in AMPK binding exhibited faster protein degradation upon autophagy 
stimulation, leading them to the conclude that AMPK phospho-sites are inhibitory to 
autophagy induction. The differences in their observations might reflect the distinct 
autophagy role of AMPK when sensing different triggers (i.e., glucose starvation 
versus amino acid starvation); they could also be due to the monitoring of different 
phosphorylation sites in these two studies. In yet another study by Shaw and 
colleagues, AMPK regulation of ULK1 was linked to mitophagy (Egan et al., 2011). 
This study identified four ULK1 sites that were phosphorylated upon treatment with 
the AMPK activators metformin and phenformin. AMPKα-null (Ampkα1-/- Ampkα2-/-) 
primary mouse hepatocytes accumulated aberrant mitochondria, suggesting a 
mitophagy defect. ULK1 with compound phospho-deficient mutations at these AMPK 
sites could not reconstitute starvation-induced p62 degradation in Ulk1-/- mouse 
embryonic fibroblasts (MEFs), suggesting that the AMPK phosphorylation on ULK1 
was required for ULK1 function in autophagy. However, the fact that AMPKα-null 
MEFs can still undergo autophagy, rules out an essential autophagic role for this 
kinase, at least in response to amino acid starvation (Kim et al., 2011; Mack et al., 
2012). It is possible that AMPK fine-tunes ULK1 activity and the subsequent 
autophagy outcome in response to various energy requirements. 
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In addition to phosphorylation, other post-translational modifications have been 
reported to regulate ULK1 and autophagy (Deribe et al., 2010; McEwan and Dikic, 
2011). Acetylation involves the transfer of acetyl groups from acetyl-CoA to the lysine 
residue of the target protein. Acetyl transferase TIP60 (HIV-1 TAT-interactive 
protein) was found to interact with ULK1 in a serum-dependent manner and could 
acetylate ULK1 directly in an in vitro reaction. Knockdown of TIP60 impaired 
starvation induced autophagy and acetylation mutants of ULK1 could not rescue LC3 
conversion in Ulk1-/- MEFs (Lin et al., 2012). The activity of TIP60 is regulated by 
GSK3B (glycogen synthase kinase 3 β), which responds to serum starvation through 
Figure 1.2 Domain structure and posttranslational modifications on ULK1. 
(A) ULK1 contains a kinase domain, a serine/proline rich region and a C-
terminal domain (CTD). Many posttranslational modification events occur within 
the Serine/Proline rich region. The CTD ends with a three residue PDZ binding 
motif that may be involved in membrane targeting. The mapped interaction sites 
with ATG13, FIP200, AMPK and members of the LC3 family are indicated. The 
site of interaction with mTORC1 complex member RPTOR is unresolved as its 
interaction with the kinase domain and the Serine/Proline rich domain has been 
reported. (B) Posttranslationally modified residues on ULK1. For brevity, only 
experimentally verified events are listed in the table. References that have 
reported these modifications are listed as well.  
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the PI3K-AKT-mTOR pathway. Hence GSK3-TIP60 stimulates autophagy in 
response to growth factor deprivation at least in part by mediating the acetylation of 
ULK1.  A genetic study on the histone acetyl transferase complexes in yeast also 
identified Esa1, the yeast homolog of TIP60, to be required for autophagy (Yi et al., 
2012). By process of elimination, Atg3 was deemed to be the substrate of Esa1, 
opening up the possibility that aside from ULK1, other autophagy essential proteins 
may be acetylated in the mammalian system as well.  
 
Protein ubiquitination is one of the most prevalent post-translational modifications 
involved in protein regulation and signal transduction. Although its best known 
function is to target proteins for degradation through the proteasome pathway through 
the formation of Lys48-linked poly ubiquitination chains, other ubiquitination marks 
have non-degradative roles such as influencing protein-protein interaction and protein 
function (Komander, 2009; Strieter and Korasick, 2012). Indications of both 
degradative and non-dgradative ubiquitination events have been found on ULK1. The 
stability of ULK1 and ATG13 are regulated by the HSP90-CDC37 chaperone 
complex. Treatment with the HSP90 antagonist 17AAG led to a decrease in ULK1 
protein levels that was rescued by co-treatment with proteasomal inhibitor MG132 
(Joo et al., 2011). This is corroborated by Johansen and colleagues who reported that 
starvation induced degradation of ULK1 can be impaired by MG132 treatment (Alemu 
et al., 2012). In a separate study, Cecconi and colleagues observed that starvation 
induced an increase in Lys63-linked poly ubiquitination (Lys63-Ub) on ULK1 (Nazio 
et al., 2013). As it was previously reported that E3 ligase TRAF6 could ubiquitinate 
ULK1 in vitro (Zhou et al., 2007), they proposed that TRAF6 is responsible for the 
Lys63-Ub observed upon starvation. In support of this, they found that TRAF6 could 
interact with ULK1. Overexpression of TRAF6 enhanced ULK1 protein level and 
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kinase activity, and conversely, depletion of TRAF6 resulted in a dramatic reduction 
in ULK1 protein levels, indicating that the Lys63-Ub modification functions to 
promote ULK1 stability and activity (Nazio et al., 2013). Taken together, the post-
translational modifications on ULK1 mediated by various energy/ nutrient sensing 
pathways provide additional versatility for cells to control the intensity and timing of 
ULK1-mediated autophagy (Figure 1.3).   
Figure 1.3 The ULK1 complex integrates nutrient and energy signals to co-
ordinate autophagy induction. Nutrient sensing pathways converge on ULK1 
through posttranslational modifications which regulate the activity to the ULK1 
complex. Light blue arrows represent events that suppress autophagy induction 
while dark blue events indicate events that stimulate autophagy induction. The gray 
arrow between AMPK and ULK1 represents the possibility that AMPK may have 
multiple regulatory effects on ULK1. 
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Early events in autophagy 
It is well established that the ULK1 complex is essential for mediating starvation-
induced autophagy. However, the functional relationship between the ULK1 complex 
and other autophagy essential proteins is still not well defined. Recruitment of the 
ULK1 complex, the VPS34 complex and the ATG5 complex to isolation membranes 
are early events in autophagy. While the ULK1 complex is not part of the core 
machinery required to bring about LC3 lipidation, a hallmark for autophagy, both the 
VPS34 complex and ATG5 complex are necessary upstream events for LC3 
lipidation. In particular, forced localization of ATG16 (member of the ATG5 
complex) to the plasma membrane was sufficient to direct ectopic LC3 lipidation to 
that membrane, indicating that the ATG5 complex specifies the site of LC3 lipidation 
(Fujita et al., 2008). VPS34 activity is also required for ATG5 complex translocation, 
placing it upstream of ATG5 (Jaber et al., 2012; Matsunaga et al., 2010; Matsunaga et 
al., 2009). As mTORC1 regulates ULK1 directly, it is logical to place the ULK1 
complex upstream of both VPS34 and ATG5 (Figure 1.4). In support of this, 
starvation induced ATG5 puncta formation is blocked in Fip200-/- cells (Hara et al., 
2008). However, the relationship between these three complexes may not be a simple 
linear one, as starvation-induced ULK1 puncta formation cannot be observed in Atg5-/- 
cells (Itakura and Mizushima, 2010), suggesting that the ATG5 complex may also 
influence the function of the ULK1 complex, perhaps by stabilizing its association to 
membranes.  
 
The VPS34 complex involved in autophagy consists of VPS34, Beclin, VPS15 and 
ATG14 (Itakura et al., 2008; Itakura and Mizushima, 2009). VPS34 is a lipid kinase 
that converts phosphatidylinositol (PI) to phosphatidylinositol-3-phosphate (PI3P) and 
can be incorporated into other complexes involved in membrane trafficking pathways 
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aside from autophagy (Brown et al., 1995; Johnson et al., 2006). The localized 
accumulation of PI3P in a subdomain of the endoplasmic reticulum (ER) recruits 
FYVE domain-containing autophagy components (WIPI, DFCP1) that result in the 
subsequent recruitment of autophagy proteins required for LC3 lipidation (ATG5 
complex and LC3) and autophagosome formation (Axe et al., 2008; Polson et al., 
2010; Proikas-Cezanne et al., 2007). Like the ULK1 complex, the VPS34 complex is 
another signaling hub and major point of regulation for autophagy induction. The 
ULK1 complex can directly regulate the VPS34 complex (Di Bartolomeo et al., 2010; 
Russell et al., 2013). Aside from ULK1, several other kinases have been reported to 
regulate members of the VPS34 complex. Some of these kinases such as EGFR (Wei 
et al., 2013), AKT (Wang et al., 2012), and AMPK (Kim et al., 2013) play a role in 
growth factor and energy-sensing pathways as well, indicating that the VPS34 
complex may be activated in co-ordination with ULK1 or in a ULK1-independnet 
manner to stimulate autophagy (Figure 1.4).   
 
1.4 The ULK1 complex: relaying nutrient signals 
Several studies have shed light on how the ULK1 complex may influence early events 
to promote autophagy. Guan and colleagues reported that ULK1 phosphorylates 
Beclin1, a member of the VPS34 complex, at Serine 14 (S14), resulting in activation 
of the autophagy-specific VPS34 complex (Russell et al., 2013). When tested in vitro, 
VPS34 complexes containing phospho-mutants of Beclin1 (S14A) were less efficient 
at generating PI3P, suggesting that the phosphorylation event promotes the lipid 
kinase activity of VPS34 (Russell et al., 2013). In an earlier study, ULK1 was shown 
to influence localization of the VPS34 complex by phosphorylating AMBRA1, a 
Beclin1 interacting protein, resulting in its release from dynein for autophagy 
activation (Di Bartolomeo et al., 2010).  
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Growing Autophagosome 
Figure 1.4 Functional relationship between the ULK1 complex, the VPS34 
complex and the ATG5 complex in autophagy. The ULK1 complex has been 
shown to directly communicate with the ATG5 complex and the VPS34 complex. 
While the role of ULK1 in amino acid starvation induced autophagy is well 
established, other triggers for autophagy may not function through the ULK1 
complex. Though currently not well understood, these triggers may stimulate the 
VPS34 complex and ATG5 complex through ULK1-independent means. 
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The ULK1 complex was also linked to ATG5 complex recruitment through direct 
interaction between FIP200 (member of the ULK1 complex) and ATG16 (member of 
the ATG5 complex) (Gammoh et al., 2013; Nishimura et al., 2013). ATG16 deficient 
MEFs are autophagy defective and unable to lipidate LC3 to PE (Ishibashi et al., 2011; 
Saitoh et al., 2008). Deletion of a FIP200 interacting domain on ATG16 resulted in a 
mutant that could not reconstitute amino-acid starvation induced autophagy (which 
requires the ULK1 complex) but could still reconstitute autophagy induced by glucose 
starvation (Gammoh et al., 2013), which is reported to occur in a ULK1-independent 
manner (Cheong et al., 2011). This indicates that the ULK1 complex promotes 
autophagy during amino acid starvation at least in part through direct recruitment of 
the ATG5 complex.  
 
In addition, ULK1 may regulate ATG9, the only transmembrane protein among the 
autophagy essential proteins (Mack et al., 2012; Young et al., 2006). In yeast, Atg9 
translocates to pre-autophagosomal structures (PAS) in an Atg1 and Atg17 dependent 
manner. Atg9 containing vesicles are thought to contribute membrane for organization 
and growth of the PAS (Mari et al., 2010; Reggiori et al., 2004; Sekito et al., 2009). 
Subsequently, Atg1 was found to directly phosphorylate Atg9 to promote autophagy 
(Papinski et al., 2014). ATG9 trafficking has been proposed to play a similar role in 
mammalian autophagy (Young et al., 2006), but this remains somewhat controversial 
as although ATG9 containing vesicles were seen to associate with autophagosomes, 
no direct fusion events were observed when live-cell imaging was used (Orsi et al., 
2012). Even though the exact function of ATG9 is still unclear and Atg9-/- MEFs are 
only partially defective in amino acid starvation induced autophagy, Atg9-/- mice share 
the same neonatal starvation phenotype as mice lacking Atg5 or Atg7 (Saitoh et al., 
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2009), indicating that ATG9 is required for starvation induced autophagy in the 
mammalian system.  
 
Thus far, the ULK1 complex is commonly described as an initiator of the autophagy 
pathway, interacting with early complexes to stimulate autophagy in response to 
nutrient status in the cell. However, recent reports indicate that ULK1 may have 
functions in later stages of autophagy as well. LC3, the mammalian homologue of 
Atg8, is conjugated to phosphatidyl-ethanolamine (PE) on nascent autophagosomes 
and is thought to promote autophagosome expansion (Ichimura et al., 2000; 
Mizushima et al., 1998). It can also facilitate autophagosome cargo selection by 
recruiting adaptor proteins such as p62 (Pankiv et al., 2007) and NBR1 (Kirkin et al., 
2009). These adaptors bind to LC3 via a conserved hydrophobic motif known as the 
LC3 interacting region (LIR). Both Atg1 (yeast) and ULK1 (mammalian) contain an 
LIR and can interact with Atg8 and LC3 respectively (Alemu et al., 2012; Nakatogawa 
et al., 2012; Okazaki et al., 2000). Mutation of the LIR abolished binding to Atg8/LC3 
and reduced starvation-induced translocation of Atg1/ULK1 to autophagosome-like 
membrane structures, indicating that the interaction with Atg8/LC3 may stabilize 
membrane association of Atg1/ULK1 and is required for autophagy (Alemu et al., 
2012; Nakatogawa et al., 2012). The exact function of this interaction is not well 
understood, but indicates that ULK1 has functions beyond its interactions with other 
early complexes (ATG5 and VPS34) and may influence later events in autophagy. 
Two other studies indicate that ULK1 may play a role in cargo loading and selection. 
Feng and colleagues found that ULK1 interacts with a mitochondria outer membrane 
protein, FUNDC1 (Wu et al., 2014). FUNDC1 was previously shown to contain an 
LIR motif and can act as an adaptor protein for mitochondrial targeting to 
autophagosomes during hypoxia-induced mitophagy (Liu et al., 2012). Feng and 
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colleagues showed that FUNDC1 is phosphorylated at Ser17 under conditions of 
hypoxia or FCCP treatment, and correlates with ULK1 status, namely Ser17 
phosphorylation increased in cells overexpressing ULK1 and was absent in Ulk1-/- 
MEFs, suggesting that ULK1 is responsible for the phosphorylation event. Phospho-
mimetic mutants (Ser17D) interacted more strongly with LC3 while Phospho-dead 
mutants (Ser17A) interacted weakly, indicating that ULK1 may promote cargo 
incorporation of mitochondria by phosphorylating FUNDC1 (Wu et al., 2014). In a 
separate study, Yue and colleagues found that ULK1 can phosphorylate p62 at its 
ubiquitin association domain (UBA) to affect the binding affinity between p62 and 
ubiquitin (Lim et al., 2015). This phosphorylation was not induced by starvation but 
increased with the accumulation of ubiquitinated proteins induced by MG132 
treatment (proteasome inhibitor). Phopho-dead mutants of p62 (S409A) resulted in the 
accumulation of protein aggregates, suggesting that the phosphorylation event 
promotes recruitment and autophagic degradation of ubiquitinated proteins (Lim et al., 
2015). Prior to this study, other groups have also reported the regulation of p62 by 
protein phosphorylation to promote autophagic degradation, albeit on different sites 
and by different protein kinases (Ichimura et al., 2013; Matsumoto et al., 2011).  
 
In summary, the ULK1 complex can regulate early complexes in autophagy to 
stimulate autophagy in response to nutrient signals but may interact with subsequent 
autophagy essential genes traditionally thought of as “late events” in autophagy as 
well. With the emergence of more data, it is becoming clear that the autophagic 
pathway is not a simple linear one but may involve multiple crosstalk and regulation 
between the autophagy complexes to achieve a highly tunable and regulated pathway.  
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1.5 Thesis objectives 
 The work described in this dissertation covers both early and late events in autophagy 
in order to advance our understanding of this pathway. Chapter 2 investigates ER 
stress-induced autophagy with the unexpected finding that the lysosomal fusion step in 
two membrane trafficking pathways, endocytosis and autophagy, though highly 
interconnected, can be independently regulated.  
 
The next part of this dissertation looks at the regulation of autophagy by the 
coordinated actions of mTORC1 and protein phosphatase 2A on ULK1, an autophagy-
initiating protein and direct substrate of mTORC1. My interest in this project was 
triggered by the observation that amino acid starvation induced more rapid 
dephosphorylation of ULK1 and autophagy induction compared to pharmacological 
inhibition of mTORC1 alone, indicating that phosphatase activity is stimulated by 
amino acid starvation. In Chapter 3, I describe identification of the Protein 
Phosphatase 2A (PP2A) complex that regulates ULK1 during amino acid starvation. 
In Chapter 4, I attempt to elucidate the mechanism behind PP2A stimulation during 
starvation and find that the interaction between PP2A and an inhibitory protein, 
Alpha4 is sensitive to amino acid starvation, and is not regulated by mTORC1. 
Deregulation of PP2A is correlated with high levels of ULK1-dependent autophagy in 
the absence of mTORC1 inactivation, indicating that “autophagy-addicted” pancreatic 
cancer cells can take advantage of PP2A mediated regulation of ULK1 to reap the dual 
benefits of autophagy and mTOR signaling at the same time. Finally, Chapter 5 
summarizes the unanswered questions raised by the work described in this dissertation 
and includes some speculation for further experimental research in our ongoing quest 
to understand the inner workings of a cell.  
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CHAPTER 2. LYSOSOMAL FUSION WITH AUTOPHAGOSOMES AND 
ENDOSOMES ARE REGULATED BY DISTINCT MECHANISMS 
 
2.1 Introduction 
A defining characteristic of Eukaryotic organisms is the presence of membrane bound 
organelles.  Eukaryotic cells make use of membrane compartmentalization to create 
sub-cellular spaces of specialized functions. Vesicle and membrane trafficking 
pathways are used to move cargo in between compartments within the cell or to move 
cargo into and out of the cell. Autophagy and endocytosis are two pathways that rely 
on the trafficking of vesicles to transport goods. Both terms were coined by Christian 
de Duve in 1963 from his observations of electron micrographs of the cell (Klionsky, 
2007). Autophagy is a degradation process that starts with an isolation membrane that 
elongates to encapsulate cytosolic contents such as damaged organelles and 
aggregated proteins. The fully formed autophagosome is a double membrane vesicle 
that eventually fuses with lysosomes resulting in degradation of its contents (Yang and 
Klionsky, 2010b). Endocytosis is the process of taking up cargo in the form of 
macromolecules or particles at the cell surface or from the extracellular environment. 
During endocytosis, a portion of the plasma membrane invaginates and pinches off 
inside the cell to form a vesicle carrying the ingested cargo. These vesicles fuse with 
early/sorting endosomes where in a series of homotypic fusion and fission events, the 
cargo is sorted and marked for transport, degradation or recycling back to the plasma 
membrane. Cargo marked for degradation are transferred to late endosomes/multi-
vesicular bodies which eventually fuse with lysosomes (Evans and Owen, 2002).   
 
The progression from early to late endosome involves a process of “Rab-conversion” 
(Cabrera and Ungermann, 2010; Hyttinen et al., 2013). Early endosomes are 
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characterized by the presence of small GTPase Rab5 and its effector proteins such as 
the class III phosphatylinositol 3-kinase Vps34 and EEA1. When early endosomes 
undergo maturation into late endosomes, they gradual lose Rab5 and gain late 
endosome marker Rab7 (Rink et al., 2005).  This conversion is facilitated by SAND-
1/Mon1 which displaces a Rab5 GEF (Rabex5) and recruits a member of the HOPs 
complex, which is required for Rab7 recruitment (Kinchen and Ravichandran, 2010; 
Poteryaev et al., 2010; Wang et al., 2002).   
 
Some parallels and overlaps exist between the autophagy and the endocytic pathway. 
Aside from sharing a common endpoint in the form of lysosomal fusion, they share 
several molecular components as well. VPS34, which produces phosphatidylinositol 
(3)-phosphate (PI3P) is involved in both pathways, resulting in an enrichment of PI3P 
in endosome, lysosome and autophagosomal membranes (Evans and Owen, 2002). 
Late endosome marker Rab7 is also required for autophagosome maturation as without 
it, autophagosomes form but are unable to fuse with lysosomes (Gutierrez et al., 2004; 
Jäger et al., 2004).  In addition, early morphological studies using cell tracers in 
combination with electron microscopy suggests that autophagosomes can not only 
fuse directly with lysosomes (Gordon et al., 1992; Lawrence and Brown, 1992) but 
can also interact with the endocytic pathway by fusing with endosomes to form 
intermediate vesicles known as amphisomes (Eskelinen, 2005; Liou et al., 1997). In an 
electron micrograph, amphisomes are characterized by the presence of endocytic 
tracer (usually in the form of endocytosed nano-gold particles) in a double-membraned 
vesicle containing other cytoplasmic material and membranous structures (Eskelinen, 
2005).  
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At a molecular level, autophagosome maturation is not well understood. Live imaging 
data suggests that autophagosome maturation may involve multiple homotypic and 
heterotypic fusion events (Jahreiss et al., 2008). The canonical RAB-SNARE fusion 
machinery involved in endocytosis is also required for autophagy (Nair et al., 2011). 
Several specific SNAREs such as VAMP7 (Fader et al., 2009), Vti1b (Furuta et al., 
2010), and Stx17 (Itakura et al., 2012) have been identified to be involved in 
autophagy maturation, but may have a role in endocytosis as well. It is unclear how 
these fusion factors are recruited to autophagosomes. Given the overlaps between the 
autophagic and endocytic pathways, it is sometimes taken for granted that they would 
share the same regulatory mechanisms for lysosomal fusion as well.  
 
In this study, we provide evidence that autophagosome maturation and endosome 
maturation, while sharing commonalities such as a Rab7 requirement, are governed by 
distinct molecular players. Treating cells with ER-stess inducer Thapsigargin, we are 
able to selectively block autophagosome maturation by preventing Rab7 recruitment 
to autophagosomes without affecting the endocytic pathway. In addition, we find that 
HOPS complex member VPS16 which is required for endocytosis, is not required for 
autophagosome clearance. Therefore although both pathways may share the same 
endpoint in the form of lysosomes, the route of vesicle maturation in autophagy may 
be governed by distinct molecular mechanisms from that in endocytosis.    
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2.2 Results 
Thapsigargin blocks autophagy 
This project was carried out in my early years as a graduate student, in close 
collaboration with a previous postdoctoral fellow in the lab, Dr. Ian Ganley, who is 
currently running his own lab at the MRC Protein Phosphorylation Unit in the 
University of Dundee. The work has been published in full in the journal Molecular 
Cell (Ganley et al., 2011) and is included here in part. Several groups have reported 
that ER stress can induce autophagy, although the molecular mechanism behind this is 
not well understood (Grotemeier et al., 2010; Ogata et al., 2006; Sakaki et al., 2008). 
Thapsigargin and tunicamycin are two small molecule inhibitors commonly used as 
experimental tools to induce ER stress. The former inhibits a calcium pump (SERCA) 
in the ER while the latter inhibits N-linked glycosylation in the ER (Szegezdi et al., 
2006). Ian laid the foundation of this project with his observation that autophagosomes 
formed during thapsigargin treatment were qualitatively different from 
autophagosomes formed during treatment with tunicamycin or starvation. Using 
mouse embryonic fibroblasts (MEFs) stably expressing autophagy marker GFP-LC3, 
he observed that while cells treated with tunicamycin or starvation formed numerous 
small GFP-LC3 puncta, thapsigargin treated cells formed larger but fewer punctate 
structures (Figure 2.1 A).  
 
Autophagy is a dynamic process in which autophagosome formation is continuously 
offset by its turnover upon fusion with lysosomes. This autophagic flux is 
demonstrated by the accumulation of autophagosomes when lysosomal function is 
disrupted, such as through the use of Bafilomycin A1, an inhibitor that binds to 
vacuolar H+ ATPase to block lysosomal acidification. Addition of bafilomycin 
resulted in a further accumulation of GFP-LC3 puncta in starvation and tunicamycin  
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Figure 2.1 Thapsigargin blocks autophagic flux. (A) MEFs stably expressing 
GFP-LC3 were incubated in amino acid starvation for 2 hr, complete media with 3 
µM thapsigargin for 5 hr or complete media with 20 µg/ml tunicamycin for 5 hr, in 
the presence or absence of 10 nM bafilomycin for the last 2 hr. (B) Time and dose 
response of MEFs treated with thapsigargin. Endogenous LC3 levels were 
monitored by immunoblotting. Quantitation of bafilomycin induced accumulation in 
LC3-II levels is shown on the right. (C) GFP-LC3 expressing MEFs were incubated 
in amino acid-free media for 1 h (starve), amino acid-free media for 1 h followed by 
addition of 50 nM wortmannin for 1 h (starve → wort), complete media with 3 µM 
thapsigargin for 4 h (TG), complete media with 3 µM thapsigargin for 4 h followed 
by addition of 50 nM wortmannin for 1 h (TG → wort), or complete media with 3 
µM thapsigargin and 50 nM wortmannin together for 4 h (TG + wort). Cells were 
then fixed and visualized by fluorescence microscopy. Bar, 10 µm. Panel A and C 
were carried out by Dr. Ian Ganley. 
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treated cells as expected (Figure 2.1 A). However, no further accumulation of GFP-
LC3 was observed in thapsigargin treated cells, indicating a block in autophagic flux.        
 
We verified these results by monitoring endogenous LC3 conversion by western 
blotting. LC3 is commonly used as a readout for autophagy. The cytosolic form of 
LC3 runs as a 17 kDa band on a gel and is known as form I. Upon autophagy 
induction, LC3 is conjugated to phosphatidylethanolamine on autophagic membranes 
and runs as a faster migrating band known as form II. In control and starvation treated 
cells, treatment with bafilomycin resulted in further accumulation of LC3-II levels. 
However although thapsigargin treatment alone resulted in an increase in LC3-II 
levels, bafilomycin treatment did not bring about a further accumulation of LC3-II, 
mirroring our earlier observations monitoring GFP-LC3. This was true for all 
concentrations and timepoints of thapsigargin treatment tested (Figure 2.1 B). This 
block in autophagic flux is not part of the ER stress response as we do not see it in 
tunicamycin treated cells (Figure 2.1 A) and IRE-1-/- MEFs deficient in the ER stress 
response (Wiseman et al., 2010) still display thapsigargin-induced block in autophagy 
flux (Figure 2.2).   
 
Thapsigargin blocks autophagosome fusion with lysosomes  
To look at this phenomenon more closely, Ian designed an elegant assay to monitor 
autophagic flux. The lipid kinase VPS34 is required for autophagy induction. 
Inhibiting its activity with wortmannin will block autophagosome formation. When 
Ian starved GFP-LC3 MEFs, he could observe numerous punctate structures, 
indicative of autophagosome formation. Addition of wortmannin to the starved cells 
resulted in gradual disappearance of the punctate structures as autophagosomes fused 
with lysosomes and were turned over. However, when the wortmannin chase assay 
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was carried out on thapsigargin treated cells, the GFP-LC3 puncta persisted and could 
not be cleared away, indicating a block in autophagosome maturation (Figure 2.1 C).  
As a control, wortmannin can block thapsigargin induced GFP-LC3 puncta formation 
when added at the start of thapsigargin treatment, indicating that the structures formed 
by thapsigargin treatment require VPS34 activity as well.  
 
As further indication that the LC3 positive structures accumulated by thapsigargin 
treatment are autophagosomes, we carried out immunofluorescence to monitor the 
translocation of p62, an adaptor protein involved in incorporating poly-ubuquitinated 
protein aggregates into autophagosomes for degradation (Bjørkøy et al., 2005; Pankiv 
et al., 2007). In starvation as well as thapsigargin treatment, we could observe good 
co-localisation between LC3 and p62, indicating successful cargo loading in both 
cases (Figure 2.3 A). Monitoring p62 levels by western blotting, we could see a 
bafilomycin-sensitive decrease in p62 levels during starvation, indicating cargo 
degradation as expected. However, thapsigargin treatment did not induce a 
Figure 2.2 Thapsigargin blocks autophagy in IRE1-/- MEFs deficient in ER 
stress response. IRE1-/- MEFs were incubated in amino acid free media for 1 hr 
(starve), complete media with 3 µM thapsigargin for 5 hr (TG) or complete media 
with 3 µM thapsigargin for 4 hr followed by amino acid free media in the presence of 
3 µM thapsigargin for 1 hr (starve + TG). Where indicated, 10nM bafilomycin was 
added for the final 1 hr of treatment. Quantitation of bafilomycin induced 
accumulation in LC3-II levels is shown on the right. 
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bafilomycin-sensitive decrease in p62 levels despite the co-localisation with LC3 
observed by immunofluorescence, once again indicating a block in autophagosome 
turnover (Figure 2.3 B).   
 
We performed electron microscopy coupled with immune-gold labeling of GFP-LC3 
to take a closer look at the structures being formed during thapsigargin treatment.  
Using four different treatment conditions, we observed a variety of membranous 
structures in the cell upon which gold label was concentrated.  In order to analyze 
these structures, we classified them into four categories: “non-circular” structures 
Figure 2.3 Cargo loading is not blocked in thapsigargin treated cells. (A) 
U2OS cells stably expressing GFP-LC3 were incubated in amino acid free media 
for 2 hr or complete media with 3 µM thapsigargin for 5 hr. Cells were then fixed 
and stained with antibodies against p62 (red) or GFP (green). Bar, 10 µm. Arrows 
indicate co-localization between p62 and LC3 and arrowheads indicate p62-only or 
LC3-only puncta. (B) U2OS cells were treated as in (A), lysed and analysed by 
immunoblotting against endogenous p62 and LC3. Quantitation of p62 levels 
relative to control are shown on the right. Panel A was carried out by Dr. Ian 
Ganley. 
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ranging 200-500 nM in length which were often linear or slightly curved, consistent 
with the morphology of isolation membranes. “Circular” structures 200-600 nM, 
which sometimes contained cellular material, consistent with the morphology of 
autophagosomes. “Internal only” structures that contained gold label on the interior of 
a limiting membrane, consistent with the morphology of autolysosomes  
(autophagosomes that have fused with lysosomes) and “circular clusters” which we 
defined as a collection of two or more circular structures in close proximity (Figure 
2.4). Cells kept in normal culture conditions (control) contained very few gold labeled 
structures, consistent with low basal levels of autophagy. Starved cells contained high 
levels of isolation membrane, autophagosome and autolysosome-like structures, 
reflecting high autophagy flux. Thapsigargin treated cells also had high levels of 
autophagosome-like structures but relatively low levels of isolation membrane-like 
structures and almost no autolysosome-like structures, indicating successful 
autophagosome formation but no turnover. In addition, thapsigargin treatment had no 
effect on starvation-induced increase in isolation membrane-like structures, but almost 
completely blocked the starvation-induced increase in autolysosome-like structures, 
supporting the notion that thapsigargin has no effect on autophagy initiation or 
autophagosome formation but blocks autophagosome fusion with lysosomes (Figure 
2.4). Another striking observation was the over representation of “autophagosome 
clusters” in thapsigargin treated samples, and suggests that some of the larger GFP-
LC3 puncta detected during fluorescence microscopy (Figure 2.1 A) could be due to 
the clustering of multiple autophagosomes. 
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Figure 2.4 Autophagosomes accumulate and cluster in thapsigargin-treated 
cells. MEFs stably expressing GFP-LC3 were treated as indicated, stained for 
GFP-LC3 and imaged by electron microscopy. Stained GFP-LC3 structures were 
categorised into 4 groups: non-circular, circular, internal only and circular 
clusters. Bars represent mean number of structures per cell section ± SEM for 
control treated cells (n = 73 cell sections), 1 h 30 min amino acid-free media 
treated cells (starve; n = 84 cell sections), 4 h 30 min thapsigargin (3 µM) treated 
cells (TG; n = 103 cell sections), and 4 h 30 min thapsigargin (3 µM) plus amino 
acid starvation for the final 1 h 30 min (TG + starve; n = 89 cell sections). Panels 
below the chart represent examples of the indicated structures. Bar, 500 nm. 
 28"
Block is specific to autophagy but does not affect endocytosis 
To check if other membrane trafficking pathways are affected by thapsigargin, Ian 
monitored the turnover of epidermal growth factor receptor (EGFR), which occurs 
through receptor-mediated endocytosis. Upon the binding of EGF, EGFR is 
internalized by endocytosis and in a process involving multiple fusion events, is 
eventually degraded in lysosomes. This turnover can be blocked by bafilomycin 
treatment, which inhibits lysosomal function and therefore all degradative pathways 
terminating in lysosomes (including autophagy). However, using a concentration that 
blocks autophagosome clearance, thapsigargin treatment had no effect on EGFR 
degradation (Figure 2.5), suggesting that thapsigargin does not block lysosome 
function per se but is specifically affecting fusion events required for autophagosome 
maturation. In addition, the ability to block autophagy without blocking endocytosis 
indicates that late events in the two pathways are not completely convergent and may 
involved distinct molecular components. 
 
Figure 2.5 Thapsigargin does not block receptor mediated endocytosis and 
degradation of EGFR. MEFs were stimulated with 40 ng/ml EGF in the presence 
of 20 µg/ml cycloheximide and in the presence or absence of 3 µM thapsigargin or 
10 nM bafilomycin. Cells were harvested at the indicated time and immunoblotted 
for EGFR levels. EGFR levels from three independent experiments are quantitated 
on the right as percentage relative to time 0. Figure 2.5 was carried out by Dr. Ian 
Ganley. 
  
 29"
The molecular mechanisms governing autophagosome maturation are not well 
understood, however Rab7 is reported to be required (Gutierrez et al., 2004; Hyttinen 
et al., 2013). Monitoring Rab7 by immunofluorescence, Ian found that starvation 
induced partial Rab7 co-localisation with LC3, reflecting the involvement of Rab7 in 
multiple pathways as well as indicating successful recruitment of Rab7 to 
autophagosomes (Figure 2.6). In contrast, although thapsigargin treatment induced 
numerous LC3 positive punctate structures, there was a large reduction in co-
localisation with Rab7 containing structures, indicating that thapsigargin somehow 
interferes with the recruitment of Rab7 to autophagosomes (Figure 2.6). In an effort to 
further investigate the effect of thapsigargin, we knocked down Rab7 and VPS16, a 
member of the HOPs complex which is reported to mediate fusion events in endosome 
maturation (Balderhaar and Ungermann, 2013; Luzio et al., 2009). In line with their 
reported functions, knockdown of Rab7 or VPS16 resulted in impairment of EGFR 
turnover (Figure 2.7 A). Surprisingly, knockdown of Rab7 but not VPS16 blocked  
  
Figure 2.6 Thapsigargin inhibits Rab7 recruitment to autophagosomes. MEFs 
were incubated in amino acid free media or complete media with 3 µM 
thapsigargin. Cells were stained with antibodies against Rab7 (green) or LC3 (red) 
and imaged by confocal microscopy. Bar, 10 µm. Percentage of LC3 structures co-
localizing with Rab7 is quantitated on the right. Figure 2.6 was carried out by Dr. 
Ian Ganley. 
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Figure 2.7 Rab7 but not Vps16 is required for autophagosome fusion with 
lysosomes. (A) (i) EGFR degradation assay to assess receptor mediated 
endocytosis was carried out in MEFs stably expressing Vps16 shRNA and Rab7 
shRNA. Knockdown levels are shown in (ii). Quantitation of EGFR levels at 
30min relative to time 0 is shown on the far right. (B) MEFs stably expressing 
GFP-LC3 and control shRNA, Vps16 shRNA or Rab7 shRNA were incubated in 
amino acid free media for 1 hr in the presence or absence of 10 nM bafilomycin. 
Cells were lysed and assed by immunoblotting for the indicated antibodies. 
Quantitation of bafilomycin induced accumulation in LC3-II levels is shown on 
the right. (C) MEFs used in (B) were incubated in amino acid free media for 1 hr 
(starve) or amino acid free media for 1 hr followed by addition of 50nM 
wortmannin in amino acid free media for an additional 1 hr (starve → wort). 
Cells were fixed and imaged by fluorescence microscopy. Bar, 10 µm. 
Quantitation of the mean number of GFP-LC3 puncta per cell is shown on the 
right.   
 31"
autophagic flux. Starvation induced LC3 conversion and turnover in control 
knockdown and VPS16 knockdown cells (as evidenced by an increase in LC3-II and 
decrease in LC3-I levels) but not in Rab7 knockdown cells (Figure 2.7 B). In addition, 
bafilomycin treatment resulted in a further accumulation of LC3-II in control and 
VPS16 knockdown cells but not in Rab7 knockdown cells, indicating that autophagic 
flux is blocked in Rab7 knockdown cells (Figure 2.7 B). The slower rate of LC3 
turnover in VPS16 cells compared to control (assessed by decrease in LC3-I levels) 
could be due to the impaired endocytic pathway, which may contribute to efficient 
LC3 turnover through amphisome formation. In addition, using the wortmannin chase 
assay, starvation induced GFP-LC3 puncta were cleared after the addition of 
wortmannin in control and VPS16 knockdown cells but not in Rab7 knockdown cells 
(Figure 2.7 C), phenocopying what we had observed earlier in thapsigargin treated 
cells. Taken together, these experiments suggest that although overlaps exist between 
the autophagic and endocytic pathways, late events in the two pathways such as Rab7 
recruitment may be regulated by distinct molecular factors.   
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2.3 Discussion 
In this study, using several assays to monitor autophagic flux, we conclusively show 
that thapsigargin blocks autophagy, preventing autophagosome maturation and 
degradation of its contents. We started the study with an interest in the role of ER 
stress in autophagy and although thapsigargin is an ER stress inducer, its inhibitory 
effect on autophagy is unrelated to the ER stress response as tunicamycin (another ER 
stress inducer) does stimulate autophagy and IRE1-/- cells deficient in the ER stress 
response still displays thapsigargin-induced block in autophagy.   
 
The thapsigargin-induced block occurs in the late stages of the autophagy pathway, 
after autophagosome formation.  By immunocytochemistry, we could detect the 
presence of cargo adaptor protein p62 in the LC3 positive structures formed as a result 
of thapsigargin treatment. Numerous closed vesicles morphologically consistent with 
autophagosomes could also be detected via electron microscopy. Strikingly, we 
observed a high incidence of vesicle clustering in thapsigargin treated cells. This may 
be a passive consequence of autophagosome accumulation, or may contribute to the 
block in fusion either by creating stearic hindrance, (limiting access to 
endosomes/lysosomes) or interfering with the recruitment of fusion factors. 
 
Perhaps the most interesting aspect of the thapsigargin-induced block in autophagy is 
that it is specific to autophagy and does not affect the endocytic pathway, which we 
demonstrated here by monitoring receptor mediated endocytosis and degradation of 
EGFR. Autophagy and endocytosis are highly interconnected, with both pathways 
sharing common factors and terminating at lysosomes. Thus far, late events in the two 
pathways have been difficult to tease apart at a molecular level. Several groups have 
shown that depleting factors required for the endocytic pathway such as the ESCRT 
 33"
machinery (Filimonenko et al., 2007; Lee et al., 2007; Rusten et al., 2007) and 
coatomer protein COP-I (Razi et al., 2009), also disrupts autophagosome turnover, 
resulting in the accumulation of autophagosome-like structures. As both pathways are 
affected, the results could be interpreted as either 1) these factors are somehow also 
directly involved in autophagosome maturation or 2) autophagosome fusion with late 
endosomes (amphisome formation) contributes significantly to the rate of 
autophagosome turnover. It is unclear how the ESCRT machinery may influence 
membrane fusion events as its known function is in mediating membrane scission in 
the biogenesis of multivesicular bodies (late endosomes) (Wollert et al., 2009). Some 
factors mediating autophagosome fusion with the endocytic system are known, such as 
Rab7 (Gutierrez et al., 2004; Jäger et al., 2004; Pankiv et al., 2010), and SNAREs 
(Fader et al., 2009; Furuta et al., 2010; Moreau et al., 2013). However, as with the 
ESCRT complex, these components function in the endocytic pathway as well. 
 
Our results with thapsigargin show that late events in the endocytic and lysosomal 
pathways can be distinguished at a molecular level, suggesting that there are 
fundamental differences governing autophagosome and endosome maturation.  As 
thapsigargin has no effect on the endocytic pathway, it is likely that thapsigargin 
generally renders autophagosomes to be “fusion-incompetent” (unable to fuse with 
either endosomes or lysosomes). In support of this, we observe a failure to recruit 
fusion factor Rab7 in thapsigargin treated cells. Identification of the thapsigargin-
sensitive factors would shed light on the unique molecular handles differentiating 
autophagosome and endosome fusion with lysosomes.   
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2.4 Experimental Procedures 
Reagents and Antibodies 
Rabbit anti-LC3b (L7543) and mouse anti-β actin Clone AC-15 (A1978) were from 
Sigma. Rabbit anti-Rab7 (#2094S) was from Cell Signaling. Rabbit anti-EGFR (sc-03) 
were from Santa Cruz Biotech. Rabbit anti-GFP (A11122) was from Invitrogen. 
Mouse anti-α tubulin (clone DM1A) was from CalBiochem. Mouse anti-P62 
(#610832) was from BD Biosciences. Rabbit anti-Vps16 (#17776-1-AP) was from 
Proteintech Group. Thapsigargin was purchased from Sigma or Enzo Life Sciences 
with each showing identical effects on autophagy. MISSION shRNA constructs 
(pLKO-puro) targeting mouse VPS16 (TRCN0000234412) and Rab7 
(TRCN0000100883) as well as a non-target control shRNA (SHC002) were purchased 
from Sigma-Aldrich. All other chemicals were purchased from Sigma. 
 
Cell culture  
Cell lines were cultured in Dulbecco’s Modified Eagles Media (DMEM), 
supplemented with 10% fetal bovine serum, 2 mM L-Glutamine and 1X penicillin-
streptomycin at 37°C, 5% CO2. IRE-1 (α/β) null MEFs (Wiseman et al., 2010) were a 
kind gift from Dr. David Ron, University of Cambridge. Stable expression of 
transgenes such as GFP-LC3, or shRNA cassettes were carried out by retroviral or 
lentiviral transduction. Lentiviral or retroviral constructs were co-transfected with 
packaging vectors into 293Ts for virus production. Virus preparations were passed 
through a 0.45 µM PES filter and supplemented with polybrene before being used to 
transduce cells.  
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Treatment conditions and cell lysis 
For starvation treatment, cells were washed twice and incubated in DMEM lacking 
amino acids and serum for 1 hr unless otherwise indicated. For thapsigargin treatment, 
cells were incubated with complete media or amino acid free media containing 3 µM 
thapsigargin for the indicated amount of time. For thapsigargin treatment in 
combination with bafilomycin or starvation, cells were pre-treated with 3 µM 
thapsigargin for 2 hr unless otherwise stated. All samples prepared for western 
analysis were washed twice in cold PBS(-) and lysed in RIPA buffer (50 mM Tris pH 
7.5, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium 
dodecyl sulfate) supplemented with protease inhibitors and phosphatase inhibitors 
(P0044 and P5726 from Sigma). Protein concentration was determined using Bio-Rad 
Protein Assay Dye reagent (#500-0006). 
 
EGF receptor degradation assay 
MEFs were washed twice and incubated in serum-free DMEM for 3 hr. 3 µM 
thapsigargin or DMSO (for control) was added to indicated plates for an additional 2 
hr. Media was then replaced with serum-free DMEM containing 40 ng/ml EGF and 20 
µg/ml cycloheximide in the presence or absence of 3 µM thapsigargin or 10 nM 
bafilomycin. Samples were harvested at the indicated times and lysed in preparation 
for western analysis.  
 
Wortmannin chase assay 
MEFs stably expressing GFP-LC3 were plated onto glass coverslips 24 hrs prior to the 
experiment. Cells were starved in amino acid free media for 1 hr or incubated in 
complete media containing 3 µM thapsigargin for 4 hr for the formation of GFP-LC3 
puncta followed by the addition of 50 nM wortmannin in starvation media or complete 
 36"
media containing 3 µM thapsigargin respectively for 1 h. Cells were then fixed in 
3.7% formaldehyde, mounted onto microscope slides and visualized by fluorescence 
microscopy.    
 
Electron microscopy coupled with immunogold labeling  
MEFs stably expressing GFP-LC3 were grown on Thermanox coverslips (Nunc). 
Treatment conditions were carried out as described above. Cells were permeabilized 
by snap freezing in liquid nitrogen followed by fixation in 3.7% formaldehyde. 
Immuno-labeling was carried out by incubating with rabbit anti-GFP antibody for 30 
min, followed by 3 washes and incubation with anti-rabbit Nanogold Fab fragments 
for 30 min (Nanoprobes). To enhance the signal, GoldEnhance (Nanoprobes) was used 
according to manufacturers instructions, with 2 min incubation. Samples were fixed in 
2.5 % Glutaraldehyde/ 2 % formaldehyde in 0.075 M Sodium Cacodylate buffer pH 
7.5 for 1 hr. Samples were rinsed in Cacodylate buffer and post fixed in 2 % Osmium 
Tetroxide for 1 hr then rinsed in double distilled water and dehydrated in a graded 
series of alcohol (50%, 75%, 95% and absolute alcohol), followed by Propylene Oxide 
and overnight in 1:1 Propylene oxide/ Poly Bed 812 resin. Ultra thin sections were 
obtained with a Reichert Ultracut S microtome. Sections were stained with Uranyl 
Acetate and Lead Citrate and imaged using a Jeol 1200 EX 11 transmission electon 
microscope.         
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CHAPTER 3. ULK1 IS REGULATED BY PROTEIN PHOSPHATASE 2A 
 
3.1 Introduction 
The ULK1 complex is essential for autophagy induced by amino acid starvation 
(referred to simply as starvation herein) and is directly regulated by energy and 
nutrient sensing kinases mTORC1 and AMPK (Ganley et al., 2009; Kim et al., 2011; 
Shang et al., 2011). Physiologically, mTOR kinase is active under nutrient rich 
conditions and directly phosphorylates ULK1 on multiple serine/threonine (Ser/Thr) 
sites, resulting in inhibition of ULK1 activity. During starvation, mTORC1 is inactive 
and inhibitory phosphorylations on the ULK1 complex are lifted, correlating with 
robust autophagy induction (Ganley et al., 2009; Jung et al., 2009). Thus, the 
reversible Ser/Thr phosphorylation of ULK1 appears to be a powerful signaling 
mechanism through which starvation induced autophagy is regulated. Interestingly, I 
observe that ULK1 is dephosphorylated more rapidly during amino acid starvation 
compared to pharmacological inhibition of mTORC1. Since mTORC1 inactivation 
alone is insufficient to account for ULK1 dephosphorylation during starvation, I 
hypothesize that phosphatase activity toward ULK1 is stimulated by starvation, and 
may represent another signaling node from which autophagy can be regulated. While 
the kinases regulating ULK1 phosphorylation are well documented, relatively little is 
known about the phosphatases involved in this process.  
 
Historically, the study of kinases and phosphatases has been closely intertwined, and 
understandably so since one catalyses the reverse reaction of the other. The first 
protein Ser/The phosphatase, “PR enzyme”, was initially discovered by Carl and Gerty 
Cori in 1945 for its ability to inactivate glycogen phosphorylase, converting it from an 
active form which they termed “phosphorylase a” to an inactive form “phosphorylase 
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b” (Cori and Cori, 1945). However, it was unclear how PR enzyme was doing this and 
its biochemical activity as a phosphatase was not recognized until the late 1950s when 
Fischer and Kerbs identified Phosphorylase Kinase, which converted phosphorylase b 
to phosphorylase a by catalyzing the transfer of the γ-phosphate group on ATP to a 
serine residue on phosphorylase b (Fischer et al., 1959; Krebs and Fischer, 1956; 
Krebs et al., 1958). They then deduced that the “PR enzyme”, identified almost a 
decade earlier, catalysed the reverse reaction resulting in release of inorganic 
phosphate (Krebs and Fischer, 1956). Thus the concept of reversible protein 
phosphorylation as a regulatory mechanism was born. This and the subsequent 
historical development of protein phosphorylation and signal transduction as a field is 
masterfully chronicled elsewhere by Phillip Cohen (Cohen, 2002) and David 
Brautigan (Brautigan, 2013).  
 
Sequencing technology has brought us a long way from the days that kinases and 
phosphatases were identified individually by biochemical purification. Due to the 
conserved nature of the kinase catalytic domain, potential kinases can be identified 
based on sequence information. The human genome contains 518 putative kinases, of 
which 428 are Ser/Thr kinases (Johnson and Hunter, 2005; Manning et al., 2002). Due 
to differences in catalytic mechanisms, phosphatase prediction is less straightforward 
as there is little sequence homology between the catalytic domain of different 
phosphatase families (McConnell and Wadzinski, 2009). This implies that a 
phosphatase must be known to find other potential members of the same family by this 
method. Based on the sequence of currently known phosphatases, the human genome 
is thought to encode approximately 30 putative Ser/Thr phosphatases (Cohen, 2004; 
Shi, 2009). At a glance, this mismatch in numbers would indicate that each Ser/Thr 
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phosphatase targets multiple kinase substrates. How then can phosphatase substrate 
specificity, if any, be achieved? 
 
The protein Ser/Thr phosphatases are broadly characterized into 3 families: the 
phosphoprotein phosphatase family (PPP), the metal dependent phosphatase family 
(PPM), and the aspartate-based phosphatase family (FCP), characterized by its 
founding member, FCP1 (Brautigan, 2013; Shi, 2009). While the PPM and FCP 
phosphatases are generally thought to function as monomers, relying on additional 
domains and sequence motifs for substrate recognition, some members of the PPP 
family form multimeric holoenzyme complexes with a variety of regulatory proteins 
that determine the subcellular localization, activity and substrate affinity of the 
catalytic subunit (McConnell and Wadzinski, 2009; Shi, 2009; Virshup and 
Shenolikar, 2009). This combinatorial approach generates phosphatase holoenzyme 
diversity that far exceeds what is suggested by the number of genes encoding catalytic 
subunits alone. In addition, post-translational modifications on catalytic and regulatory 
subunits add an additional handle for regulating the spatial and temporal assembly of 
phosphatase complexes (Janssens et al., 2008).  
 
Aside from these 30 classically described Ser/Thr phosphatases, the human genome 
contains an estimated 60 genes that encode Dual Specificity Phosphatases (DUSPs). 
The DUSPs are traditionally classified as tyrosine phosphatases (based on their 
catalytic structure) but can also dephosphorylate Ser/Thr residues (Alonso et al., 
2004).    
 
While phosphatases were once erroneously believed to be constitutively active and 
promiscuous enzymes, this view is slowly being overturned with the continual 
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discovery of interacting proteins that bind to phosphatase catalytic subunits to regulate 
their activity. In this Chapter, I monitor two mTORC1 sites on ULK1 and find that 
more than one phosphatase acts in opposition to mTORC1 to dephosphorylate ULK1 
during starvation. I conclusively identify one of the phosphatases regulating ULK1 to 
be the PP2A-B55α complex, and will discuss regulation of the phosphatase in the 
following chapter.  
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3.2 Results  
ULK1 is rapidly dephosphorylated during starvation  
ULK1 is phosphorylated on multiple sites by mTORC1 and rapidly dephosphorylated 
during starvation (Ganley et al., 2009). Phosphorylation sites on ULK1 have been 
mapped by several groups, among which S637 and S757 were identified by three or 
more independent groups (Egan et al., 2011; Kim et al., 2011; Mack et al., 2012; 
Shang et al., 2011). Phospho-specific antibodies recognizing ULK1 S637 and S757 
phosphorylation (Shang et al., 2011) were used to monitor ULK1 in this study. In 
collaboration with an attachment student in the lab (Rong Shi), we verified the 
specificity of the antibodies using Ulk1-/-Ulk2-/- double knockout (ULK1/2 DKO) 
MEFs reconstituted with Flag-S-doubly tagged ULK1. The antibodies picked up a 
signal only in cells ectopically expressing ULK1, and decreased upon starvation as 
previously reported. Interestingly, a kinase dead version of ULK1 (K46I) underwent 
dephosphorylation at a slower rate compared to wild type ULK1 (Figure 3.1 A).   
Figure 3.1 ULK1 S637 and S757 phospho antibody validation. (A) No signal 
is detected in ULK1/2 DKO MEFs. The antibodies recognized ectopic ULK1 
(WT and K46I mutant) expressed in ULK1/2 DKO MEFs, and the signal was 
reduced upon starvation, correspondent with dephosphorylation of ULK1. (B) 
The antibodies cannot recognize ULK1 when the respective sites of ULK1 
(S637, S757) are mutated to alanine. Panel B was carried out by Rong Shi. "
A B 
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Mutating the respective serine residues to alanine resulted in a loss of signal, 
indicating that the anitbodies specifically recognize the phosphorylated form of ULK1 
(Figure 3.1 B). 
  
Phosphatase activity is required for autophagy induction 
To identify the phosphatase for ULK1, I first tested the effect of Okadaic acid (OA), a 
pharmacological inhibitor of the phosphoprotein phosphatase (PPP) family (Swingle 
et al., 2007). OA treatment inhibited starvation-induced dephosphorylation of ULK1 at 
S637 in a dose dependent manner, but had no effect on the dephosphorylation of S6K 
T389 and other well established mTORC1 substrates 4EBP1 and DAP1 (Figure 3.2 
and Figure 3.3 B). Remarkably, OA treatment also did not inhibit dephosphorylation 
of ULK1 at S757, suggesting that more than one phosphatase is involved in the 
regulation of ULK1 (Figure 3.2). As a positive control, OA could inhibit 
Figure 3.2 Okadaic Acid (OA) inhibits 
ULK1 S637 dephosphorylation in a dose 
dependent manner. MEF cells were 
incubated in starvation media with 
increasing amounts of OA for 1 hr. 
Phosphorylation on ULK1 and S6K were 
monitored using site specific phospho-
antibodies. AKT, previously reported as 
OA sensitive, was included as a positive 
control for OA treatment. 
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dephosphorylation of AKT, which has been reported to be sensitive to OA (Gao et al., 
2005). This observation was consistent in all tested cell lines, ruling out the possibility 
of a cell line specific artifact (Figure 3.3 A)   
 
The inhibition in ULK1 dephosphorylation translated to a decrease in autophagy 
response to starvation as evidenced by reduced lipidation of endogenous LC3 and 
decreased puncta formation of GFP-LC3 in the presence of OA (Figure 3.3 B and C). 
Autophagy is a multistep process that ultimately leads to autophagosome fusion with 
lysosomes hence it is conceivable that OA treatment may affect dephosphorylation of 
proteins other than ULK1 to bring about the block in autophagy. However, as the 
ULK1 complex has been shown to be indispensible for efficient induction of 
autophagy in response to starvation, I favor the hypothesis that ULK1 
dephosphorylation is one of the key events being blocked. In support of this, two early 
events in autophagosome formation: the translocation of ULK1 itself and recruitment 
of ATG16 complex to punctate structures is greatly reduced in OA treated cells 
(Figure 3.3 C).  
 
PP2A dephosphorylates ULK1 at S637 
OA is a potent inhibitor of several PPP family members, with a reported IC50 in the 
nano molar range when used in vitro (Swingle et al., 2007). Of the PPP family 
members inhibited by OA, PP1 and PP2A are the most abundant and ubiquitously 
expressed in cells, hence were the clearest candidates to start off with. Knockdown of 
the PP2A catalytic subunit (PP2AC) or scaffolding subunit (PRL65) clearly blocked 
starvation induced dephosphorylation of Ulk1 at S637 (Figure 3.4 A and B) whereas 
knockdown of PP1 catalytic subunit (PP1C) had no effect despite a near complete 
depletion of PP1C (Figure 3.4 C). Remarkably, knockdown of either  
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Figure 3.3 Okadaic acid (OA) treatment inhibits autophagy. (A) OA  inhibits the 
dephosphorylation of ULK1 at S637 but not S757. MEF, U2OS or HT1080 cells 
were incubated in starvation media or starvation media with 200 nM OA for 1 hr. 
(B) MEFs were treated as in (A) and lysates were probed for three reported mTOR 
substrates (S6K, 4EBP1 and DAP1) and endogenous LC3. (C) MEFs stably 
expressing GFP-LC3, GFP-ULK1 or GFP-ATG16 were incubated in starvation 
media or starvation media containing 200 nM OA for 1 hour. Cells were fixed and 
imaged for GFP-LC3, GFP-ULK1 or GFP-ATG16 translocation. Average number of 
puncta per cell were quantitated and expressed as such or as fold change relative to 
full media (fold change or mean ± s.d., n=20. two-tail student’s t-Test, * p<0.05).   
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Figure 3.4 PP2A but not PP1 dephosphorylates ULK1 at S637. (A, B) PP2A is 
required for dephosphorylation of ULK1 at S637. MEFs were transduced with 
lentivirus containing control shRNA, shRNA targeting the catalytic subunit of 
PP2A (PP2AC) or scaffolding subunit of PP2A (PRL65). 48-72 hrs post 
transduction, cells were incubated in starvation media and lysed for immuno-
blotting. (C) PP1C is not required for ULK1 dephosphorylation. MEF cells were 
treated as in (A) with shRNA targeting the catalytic subunit of PP1 (PP1C). (D) 
PP2AC directly dephosphorylates ULK1 S637 in vitro. Catalytic subunit of PP1 
(PP1C) was included as a control. Flag-S-ULK1 substrate was incubated with 50 
nM of recombinant PP2AC or PP1C at 30oC for 20 min. (E) Diagram representing 
the PP2A Ser/Thr phosphatase complex. Regulatory subunits confer substrate 
specificity to the core enzyme. 
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phosphatase had no significant effect on S757 dephosphorylation, supporting my 
earlier observation that S757 is regulated by a different phosphatase. In order to verify 
that ULK1 is a direct substrate of PP2A, I carried out an in vitro phosphatase reaction 
using recombinant proteins of PP1 and PP2A catalytic subunits. Indeed, the substrate 
specificity displayed in cells could also be recapitulated in vitro as PP2AC but not 
PP1C could dephosphorylate ULK1 at S637 and neither phosphatase could 
dephosphorylate ULK1 at S757 (Figure 3.4 D).    
 
Identification of PP2A regulatory subunit involved in autophagy 
In cells, PP2A functions as a heterotrimer consisting of a catalytic subunit, a 
scaffolding subunit and a variable regulatory subunit (Figure 3.4 E). It is generally 
thought that the regulatory subunit confers substrate specificity and thus dictates the 
biological function of the phosphatase complex (Janssens et al., 2008; Mumby, 2007). 
I sought to identify the regulatory subunit targeting ULK1 by biochemical 
fractionation, hence developed an in vitro assay to measure phosphatase activity 
against ULK1 (Figure 3.5). With great help from my thesis advisor, Dr. Xuejun Jiang, 
we were able to purify the regulatory subunit from whole cell lysate after a series of 
Figure 3.5 Set up of in vitro phosphatase assay used to purify regulatory 
subunit. Left panel shows a shematic of the phosphatase assay. The substrate 
(Flag-S-ULK1) was expressed in 293Ts to ensure proper phosphorylation and 
isolated by Flag immune-precipitation. Right panel shows the reaction. The 
substrate is stable in the reaction over time and dephosphorylated only in the 
presence of an enzyme source (total or fractionated cell extract)."
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seven chromatographic steps (Figure 3.6 A). Large scale cultures of ULK1/2 DKO 
MEFs were used for the fractionation as they lacked endogenous ULK1 that could 
interfere with the assay results. After each run of a chromatographic column, fractions 
were analyzed for phosphatase activity against ULK1 S637. A representative example 
is shown in Figure 3.6 B. Active fractions were combined and loaded onto the next 
column. From relatively early on in the purification, it was clear that only a sub 
population of PP2A in the cell could dephosphorylate ULK1 S637 (Figure 3.6 B and 
C). Fractions from the final column were analyzed by SDS-PAGE followed by silver 
staining (Figure 3.6 D). Three distinct bands at 36 kDa, 65 kDa and 55 kDa could be 
detected in fractions that correlated with phosphatase activity against ULK1 S637. As 
expected, mass spectrometry analysis identified the 36 kDa and 65 kDa bands to be 
the PP2A catalytic and scaffolding subunits respectively. The 55 kDa band was PP2A 
regulatory subunit B55α (Figure 3.7). As an initial validation step the purification was 
repeated with minor changes to the original scheme and fractions were analyzed for 
B55α distribution (Figure 3.6 E). B55α correlated perfectly with PP2AC-containing 
fractions that were active against ULK1 (Figure 3.6 E, fractions 11 and 12). In line 
with being a regulatory subunit with no catalytic activity on its own, fractions 
containing B55α but no PP2AC had no activity against ULK1 (Figure 3.6 E, fractions 
7 and 8).  
               
Regulatory subunit B55α directs PP2A phosphatase activity against ULK1 
To verify that B55α was truly the regulatory subunit directing PP2A activity towards 
ULK1 in cells, I carried out shRNA knockdown of B55α using a lentiviral based tet-
inducible system. Two independent shRNAs targeting B55α were designed, one 
targeting the 3’UTR region of B55α (shRNA1) and another targeting the coding 
region of B55α (shRNA2). Both shRNA sequences efficiently inhibited ULK1  
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Figure 3.6 Identification of PP2A regulatory subunit by biochemical 
purification. (A) Purification scheme used to identify the PP2A regulatory subunit 
from starved ULK1/2 DKO cell lysate. (B,C) Examples of phosphatase assay 
reaction during PP2A regulatory subunit purification. Fractions from Phenyl 
Sepharose column and Hydroxyapatite column were assessed for activity against 
ULK1. (D) Silver staining (top) and phosphatase activity assay (bottom) of 
fractions from the final purification step. Active fractions are boxed in red. 
Indicated bands were excised for mass spectrometric analysis. (E) Western blot 
showing distribution of PP2AC, B55α, and ULK1 S637 phosphatase activity after a 
Q column."
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Figure 3.7 Mass spectrometry analysis of p36, p65 and p50 bands from ULK1 
phosphatase purification. The peptides detected during mass spectrometry 
analysis are shown in red. (A) The p36 band produced peptide fragments that 
matched to the catalytic subunit of PP2A with a sequence coverage of 38.5%. (B) 
Peptide fragments from the p65 band matched to the scaffolding subunit of PP2A 
with a sequence coverage of 37.2%. (C) Peptide fragments from the p50 band 
matched to the B55α regulatory subunit of PP2A with a sequence coverage of 
43.2%. Identified proteins: At p<0.01, average false discovery rate, FDR: 0%. 
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dephosphorylation at S637 (Figure 3.8 A) and resulted in a reduction in starvation-
induced autophagy, as assessed by turnover of endogenous LC3 as well GFP-LC3 
puncta formation (Figure 3.8 A and C). Expression of shRNA resistant Flag-S-B55α 
was sufficient to reverse the effects of B55α knockdown on ULK1 S637 
dephosphorylation, indicating that the inhibition in dephosphorylation is specifically 
due to reduction in B55α levels (Figure 3.8 B).  
 
Crystal structure data of the PP2A hetero-trimer suggests that the regulatory subunit 
greatly facilitates substrate recognition and recruitment (Xu et al., 2008). I therefore 
checked if B55α could interact with ULK1 in cells. Upon co-overexpression of ULK1 
together with either B55α or an unrelated regulatory subunit from another family 
(PR72), I found that ULK1 could interact more strongly with B55α compared to 
PR72, suggesting that B55α indeed plays a significant role in directing the PP2A 
complex to ULK1 in cells.  
  
To demonstrate that B55α makes PP2A a more efficient phosphatase towards ULK1, I 
reconstituted the phosphatase reaction in vitro using recombinant proteins of PP2AC, 
PRL65 and B55α. Recombinant PP2AC and PRL65 were co-expressed in insect cells 
using baculovirus vectors while B55α was expressed and purified to homogeneity 
separately.  As I had shown previously that PP2AC alone is sufficient to 
dephosphorylate ULK1 in vitro when used at sufficiently high concentrations (Figure 
3.4 D), I titrated down the amount of PP2AC in the reaction from the 50 nM used 
earlier to 5 nM. When used at 5 nM on its own, the catalytic subunit could barely 
dephosphorylate ULK1 after 20 min of incubation at 30 oC. However, with the 
addition of B55α to the reaction, the same amount of PP2AC could dephosphorylate 
ULK1 much more efficiently. The stimulatory effect of B55α on PP2A activity 
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occurred in a dose dependent manner and B55α alone when used at its highest dose 
had no phosphatase activity against ULK1, indicating that the increase in phosphatase 
activity was due to a synergistic effect between B55α and PP2AC rather than an 
experimental artifact due to contaminating phosphatases in the protein preparation 
(Figure 3.8 E).       
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Figure 3.8 Regulatory subunit B55α directs PP2A phosphatase activity 
against ULK1. (A) B55α is required for ULK1 S637 dephosphorylation. HT1080 
cells expressing tet-inducible shRNAs were cultured in 100 ng/ml Doxycycline 
and incubated in starvation media. (B) Over- expression of Flag-S- B55α can 
rescue the effect of B55α shRNA1 in HT1080. (C) Knockdown of B55α in 
HT1080 blocks starvation-induced autophagy as monitored by florescence imaging 
of GFP-LC3. Average number of puncta per cell was quantitated and expressed as 
fold change relative to 0 min (fold change ± s.d., n=20. two-tail student’s t-Test, * 
p<0.05) (D) ULK1 interacts preferentially with B55α. 293Ts were co-transfected 
with Flag-S-ULK1 and GFP-B55α or GFP-PR72 (regulatory subunit from a 
different family). Cells were lysed and incubated with S-beads. (E) B55α 
stimulates PP2A activity towards ULK1. In vitro phosphatase assay was carried 
out using 5 nM of recombinant PP2AC co-purified with PRL65 and increasing 
amounts of B55α (10 nM or 40 nM). Coomassie brilliant blue staining of 
recombinant protein preparations is shown on the right.  
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3.3 Discussion 
For awhile okadaic acid has been known to inhibit autophagy in hepatocytes 
(Blankson et al., 1995; Holen et al., 1993) and some neurodegenerative models 
(Magnaudeix et al., 2013) but it was never clear how this occurred mechanistically. 
Here we show that OA exerts its inhibitory effects at an early stage of autophagy and 
identify an OA sensitive phosphorylation site on key autophagy protein; ULK1. It 
should be noted that as many as 30 phosphorylation sites on ULK1 has been detected 
by mass spectrometry (Dorsey et al., 2009; Wong et al., 2013). Hence data on the two 
sites monitored in this study (S637 and S757) each most likely represent the behavior 
of a subset of phosphorylation sites on ULK1. Although it is not addressed in this 
study, OA may block dephosphorylation of other early autophagy genes as well, such 
as Beclin 1, a reported substrate of AKT (Wang et al., 2012), and ATG13, which is 
also a member of the ULK1 complex and a reported substrate of mTORC1 (Jung et 
al., 2009).  
 
Through a combination of pharmacological inhibition, shRNA knockdown and 
biochemical fractionation, I identified the phosphatase regulating ULK1 S637 to be 
the PP2A-B55α complex. Prior to this study, two PP2A complexes had been 
implicated in the regulation of autophagy in drosophila, although the substrates of 
PP2A were not identified (Bánréti et al., 2012). Interestingly, while the effects on 
ULK1 S637 were clear, in my hands OA treatment and subsequently knockdown of 
PP2AC did not affect dephosphorylation of other mTOR substrates S6K and 4EBP1, 
suggesting that different substrates of the same kinase may be regulated by distinct 
phosphatases. The substrate specificity of PP2A is also demonstrated at an intra-
molecular level as the second site monitored in this study (ULK1 S757) was not 
dephosphorylated by PP2A in both our cellular experiments and in all subsequent in 
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vitro phosphatase assays. As there are numerous examples of multiple kinases 
targeting different sites on the same protein, it perhaps should not come as a surprise 
that the same phenomenon may be true for phosphatases. A search of literature 
revealed that AKT is also regulated by more than one phosphatase, with AKT T308 
being a substrate of PP2A while dephosphorylation of AKT S473 is mediated by 
PHLPP (PH domain leucine-rich repeat protein phosphatase); a member of the PPM 
phosphatase family (Gao et al., 2005).  
  
The PP2A holoenzyme is a hetero trimer consisting of a scaffolding (A), a regulatory 
subunit (B) and a catalytic (C) subunit (Eichhorn et al., 2009). As we and others have 
shown, the core enzyme consisting of the A-C dimer has activity in vitro when used at 
sufficiently high concentrations (Xu et al., 2008). This may have contributed to early 
views of PP2A as a promiscuous enzyme. It is not clear if A-C dimmers without 
regulatory subunits exist in the cell. In this study, I identified the regulatory subunit 
targeting PP2A to ULK1 to be B55α and demonstrated that B55α can synergistically 
increase PP2A activity towards ULK1 in vitro, supporting its proposed function in 
substrate recruitment (Xu et al., 2008). During the purification of B55α, it was clear 
that only a sub population of PP2A in the cell could dephosphorylate ULK1 S637. 
Depletion of B55α also greatly impaired starvation induced ULK1 S637 
dephosphorylation and autophagy induction, indicating that the PP2A-B55α complex 
mediates autophagy induction.   
 
PP2A regulatory subunits are classified into four distinct families, termed R2/PR55/B, 
R3/PR72/B’’, R4 and R5/PR61/B’ with little sequence homology between families 
(Janssens et al., 2008; Mumby, 2004). The B55α subunit is reported to be one of the 
most widely expressed regulatory subunits in cells (Mumby, 2004) and has been 
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reported to target PP2A other substrates including AKT (Kuo et al., 2008), FOXO1 
(Yan et al., 2012), retinoblastoma protein (Rb) family member p107 (Kolupaeva et al., 
2013), and microtubule subunit Tau (Xu et al., 2008), though the conditions under 
which these substrates are dephosphorylated are not always well documented. It is 
thus possible that in addition to ULK1, other substrates are being dephosphorylated by 
PP2A-B55α during starvation as well. On the other hand, given the complexities of 
signaling networks in the cell, additional targeting mechanisms could be in place to 
limit the number of substrates being dephosphorylated by PP2A-B55α during 
starvation, such as localized activation of PP2A-B55α, and maintaining or increasing 
the activity of kinases regulating other PP2A-B55α substrates during starvation to 
compensate for PP2A-B55α activity.  
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3.4 Experimental Procedures 
Reagents and Antibodies 
Rabbit anti-LC3b (L7543), mouse anti-β actin Clone AC-15 (A1978), mouse anti-
B55α Clone 2G9 (SAB4200241) were from Sigma. Mouse anti-α tubulin (clone 
DM1A) was from CalBiochem. Rabbit anti-phos S6K (Thr389) (9205), Rabbit anti-
S6K (2708), Rabbit anti-4EBP1 (9452), rabbit anti-PRL65 Clone 81G5 (2041), rabbit 
anti-DAP1 (2282), rabbit anti-His Tag (2365), rabbit anti-B subunit (2290) were from 
Cell Signaling. Rabbit anti-phos-ULK1 (S637) and rabbit anti-phos-ULK1 (S757) 
were a generous gift from Dr. Xiaodong Wang, National Institute of Biological 
Science, Beijing, China.  N.B. corresponding sites in human ULK1 are S638 and S758 
respectively. Rabbit anti-total ULK1 (A7481) used to detect mouse ULK1 was 
purchased from Sigma. Rabbit anti-total ULK1 (sc33182) used to detect human 
ULK1, rabbit anti-PP2AC (sc130237) and mouse anti-PP1C (sc7482) were from Santa 
Cruz. Mouse anti-S-tag antibody (71549-3) was from Novagen. Mouse anti-PP2AC 
clone 1D6 (05-421) was from Millipore. Okadaic acid was purchased from Sigma 
(O9381) or Enzo Life sciences (ALX-350-003) with each showing identical effects on 
ULK1 dephosphorylation.   
 
Cell culture  
MEFs and U2OS cell lines were cultured in Dulbecco’s Modified Eagles Media 
(DMEM), supplemented with 10% fetal bovine serum, 2 mM L-Glutamine and 1X 
penicillin-streptomycin at 37°C, 5% CO2. ULK1/2 DKO MEF cells were courtesy of 
Dr. Craig Thompson, Memorial Sloan Kettering Cancer Center, New York, USA. 
Stable expression of transgenes such as GFP-LC3, Flag-S-B55α, or shRNA cassettes 
were carried out by retroviral or lentiviral transduction. Lentiviral or retroviral 
constructs were co-transfected with packaging vectors into 293Ts for virus production. 
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Retro/Lentivirus preparations were passed through a 0.45 µM PES filter and 
supplemented with polybrene before being used to transduce cells.  
 
Treatment conditions and cell lysis 
For amino acid starvation experiments, cells were washed twice and incubated in 
DMEM lacking amino acids and serum for the indicated amount of time. For Okadaic 
acid (OA) treatments to inhibit PPP family phosphatases, as OA is a hydrophobic 
inhibitor, cells were pretreated with 200 nM OA in full media before switching to 
starvation media with 200 nM OA to allow time for cellular uptake of OA.  
 
All samples prepared for western analysis were washed twice in cold PBS(-) and lysed 
in RIPA buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulfate) supplemented with protease inhibitors 
and phosphatase inhibitors (P0044 and P5726 from Sigma). Protein concentration was 
determined using Bio-Rad Protein Assay Dye reagent (#500-0006). 
 
Fluorescence microscopy 
Cells stably expressing the GFP tagged protein for visualization were plated onto glass 
coverslips 24 hours prior to the experiment. Following treatment, cells were fixed in 
3.7% formaldehyde for 20 min. Cover slips were washed and mounted onto 
microscope slides using ProLong Gold antifade reagent with DAPI (Molecular 
probes). Slides were visualized on a Nikon Eclipse TE2000-U microscope or a Nikon 
Eclipse Ti-U confocal Microscope. Acquired images were processed using Adobe 
Photoshop.   
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In vitro dephosphorylation assay 
Generation of substrate (Flag-S-ULK1) used in phosphatase assays 
ULK1 substrate was generated in a mammalian system to ensure proper 
phosphorylation. pBabe-Flag-S-ULK1 construct generated previously (Ganley et al., 
2009) was transfected into 293T cells using Lipofectamine2000 (Invitrogen) according 
to the manufacturer’s recommendations. Cells were split 24 hours post transfection to 
prevent overgrowth and harvested 48 hours post transfection. Cells were lysed in 
phosphatase assay buffer (50 mM Hepes, pH 7.5, 100 mM NaCl, 2 mM MgCl2, 1 mM 
DTT, 0.5% NP-40) supplemented with protease inhibitors and phosphatase inhibitors 
(P0044 and P5726 from Sigma) to preserve phosphorylation. Lysate was incubated 
with Anti-Flag M2 affinity gel (A2220 from Sigma) at 4oC with rotation overnight. 
Following 4-5 washes, Flag-S-ULK1 substrate was eluted in phosphatase assay buffer 
containing 400 µg/ml 3X FLAG peptide (Sigma).  
 
The Flag-S-ULK1 substrate was stable in reactions containing cell lysate but not in 
buffer alone when incubated at 30oC. To stabilize the substrate in reactions that use 
recombinant phosphatases, we used ULK1/2 DKO MEF cell lysate devoid of 
phosphatase activity. To generate this protective lysate, we incubated ULK1/2 DKO 
MEF cell lysate (in 20 mM Hepes pH 7.5, 50 mM KCl, 5 mM Pi, 1 mM DTT + 0.5% 
NP-40 buffer) with hydroxyapatite beads at 4oC overnight with rotation. 
Approximately 50 µl bead volume was used per mg of total cell lysate. Protective 
lysate was tested for ability to stabilize Flag-S-ULK1 substrate and lack of remnant 
phosphatase activity before use in assays (Figure 4A). Incubation with hydroxyapatite 
beads was repeated if phosphatase activity was not completely depleted. Protective 
lysate was concentrated in a Amicon Ultra-4 centrifugal filter unit (UFC801024 from 
EMD Millipore) if total protein concentration was too low.    
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For phosphatase assays with cell lysate: Flag-S-ULK1 substrate was incubated with 10 
µg of total cell lysate at 30oC for the indicated amount of time. For phosphatase assays 
with recombinant proteins or for biochemical purification of B55α subunit: Flag-S-
ULK1 substrate plus 7-10 µg of phosphatase-depleted protective lysate was incubated 
with recombinant proteins or column eluted fractions at 30oC for 20 min.  
 
Biochemical purification of B55α subunit 
A 20 ml cell pellet of starved ULK1/2 DKO MEF cells was lysed by douncing in 90 
ml of Buffer A (20 mM Hepes pH 7.5, 10 mM NaCl, 1 mM DTT). Cell lysate was 
centrifuged at 10’000 rpm for 10 min at 4oC. Supernatant was further clarified by 
centrifugation at 45’000 rpm for 1 hour at 4oC. Clarified cell lysate was loaded into SP 
column. Flow-through from SP column was collected and loaded into Heparin 
column. Flow-through from Heparin column was collected and loaded into Q column 
(Buffer A: 20 mM Hepes pH 7.5, 10 mM NaCl, 1 mM DTT;  Buffer B: 20 mM Hepes 
pH 7.5, 1000 mM NaCl, 1 mM DTT). Q column was washed with 15%B and eluted 
with 35% Buffer B. Ammonium sulfate was added to a final concentration of 20% and 
incubated at 4oC for 30 min. Precipitated proteins were removed by centrifugation at 
20,000 rpm for 10 min. Supernatant was collected and diluted to 10% Ammonium 
sulfate before loading into a Phenyl Sepharose column (Buffer A: 5 mM Hepes pH 
7.5, 1 mM DTT; Buffer B: 20% Ammonium sulfate, 20 mM Hepes pH 7.5, 400 mM 
NaCl, 1 mM DTT). Phenyl Sepharose column was eluted with a gradient of 50% to 
0% Buffer B across 20 fractions.  Fractions were dialysed and assayed for activity. 
Active fractions were combined and loaded into Hydroxyapatite column (Buffer A: 20 
mM Hepes pH 7.5, 10 mM NaCl, 1mM DTT; Buffer B: 1M Pi, 1mM DTT pH 7.5). 
Column was washed with 3% Buffer B and eluted with a gradient of 3% to 18% 
 60"
Buffer B across 20 fractions.  Fractions were dialysed and assayed for activity. Active 
fractions were combined and concentrated with a Q-column. Gel filtration column was 
run and active fractions were combined and loaded into a mono Q column (same 
buffer conditions as Q column). Mono-Q column was washed with 18% Buffer B (180 
mM NaCl) and eluted in 20 x 1 ml fractions across a 19% Buffer B (190 mM NaCl) to 
34% Buffer B (340 mM NaCl) gradient. 8 µl of each fraction was assayed for activity.    
 
Purification of recombinant proteins 
The full length of human PP2A catalytic subunit (PP2AC, α isoform NM_002715) or 
regulatory subunit B55α (human, NM_002717) was cloned into baculovirus transfer 
vector pFastBac as N-terminal 9x His-tagged proteins. Full length human PP2A 
scaffolding subunit (PRL65, α isoform NM_014225) was cloned into pFastBac as N-
terminal 9x His and Flag tandem-tagged proteins. Recombinant baculovirus was 
produced using Bac-to-Bac expression system from Invitrogen. PP2AC and PRL65 
were co-expressed in a suspension culture of Sf9 cells for co-purification. Briefly, cell 
pellets were lysed by douncing and purified by Ni-NTA resin, followed by gel 
filtration to isolate fractions containing both PP2AC and PRL65. B55α was expressed 
in Sf9 cells and purified by Ni-NTA resin followed by ion exchange chromatography 
through a Q column. 
 
Knockdown by shRNA  
The following shRNA constructs were purchased from Sigma: pLKO non-target 
control (CAACAAGATGAAGAGCACCAA), pLKO mPP2AC shRNA 
(GCGACATTGTTGGTCAAG AAT), pLKO mPRL65 shRNA 
(GCCACCAGCAACCTTAAGAAA), pLKO mPP1C shRNA 
(CCAGATCGTTTGTACAGAAAT). The following shRNAs were cloned into 
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pLKOtet-ON inducible shRNA plasmid system purchased from Addgene: hB55α sh 1 
(TCCTGCTTAGTTGAGATAGTT), hB55α sh 2 
(GTAGATGATGATGTAGCAGAA). Lenti- viruses were made by co-transfecting 
shRNA constructs and packaging vectors into 293Ts. Lentiviral preparations were 
passed through a 0.45 µM PES filter and supplemented with polybrene before being 
used to transduce cells. Stable cell lines were typically assayed for knockdown 48-72 
hours post transduction. For inducible knockdown, cell lines were grown in complete 
media containing 100 ng/ml Doxycycline 48-72 hours before assaying for knockdown. 
 
Expression constructs 
Autophagy marker LC3 was subcloned into pBabe/blast vector containing N-terminal 
GFP tag. pMIC vector was made by modifying pMIG vector (Addgene) to replace 
GFP in the backbone with mCherry. The coding sequence (cds) of human B55α or 
human PP2AC were cloned into pMIC vector along with an N-terminal Flag-S tandem 
tag. pMSCV GFP-B55α and pMSCV GFP-PR72 used in immunoprecipitation 
experiments were a generous gift from Dr. Emily Foley, Memorial Sloan Kettering 
Cancer Center, New York, USA. 
 
Immunoprecipitations 
Constructs expressing Flag-S-ULK1 and GFP-B55α or GFP-PR72 were co-transfected 
into 293Ts using Lipofectamine 2000 (Invitrogen) according to the manufecturer’s 
recommendations. 24-48 hours post transfection, cells were washed twice in cold 
PBS(-) and lysed in IP buffer (20 mM Tris pH 7.5, 150 mM NaCl, 1 mM DTT, 0.5% 
Triton X-100) supplemented with protease inhibitors. Cell lysate was centrifuged at 
20,000 x g for 10 min at 4oC and incubated with 10 µl of S-protein agarose beads 
(69704 from EMD Millipore) in a total volume of 1 ml overnight at 4oC with rotation.  
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CHAPTER 4. PHOSPHATASE ACTIVITY IS STIMULATED BY AMINO ACID 
STARVATION 
 
4.1 Introduction 
Amino acid starvation is a well characterised trigger for autophagy in both yeast and 
mammalian cells. At the center of signaling events leading to starvation-induced 
autophagy is inactivation of the mTOR kinase and concurrent activation of the ULK1 
complex (Chan, 2009; Ganley et al., 2009). ULK1 is a direct substrate of mTORC1 at 
several sites including S637 and S757 and undergoes global dephosphorylation upon 
starvation (Shang et al., 2011). In the previous chapter, I identified the phosphatase 
complex regulating ULK1 S637 to be PP2A-B55α.  
 
PP2AC is one of the most abundant and ubiquitously expressed Ser/Thr phosphatases 
in the PPP family. In some cell types, it may account for up to 1% of total cellular 
proteins (Slupe et al., 2011). PP2A has been implicated in the regulation of many 
cellular processes including cell survival, cell cycle control, proliferation and death, 
cytoskeletal dynamics and migration (Shi, 2009; Virshup and Shenolikar, 2009). 
Given its abundance and involvement in multiple cellular processes, regulation of 
PP2A is understandably complex. PP2A functions as a heterotrimeric complex 
composed of a catalytic (PP2AC), a scaffolding (PRL65) and a variable regulatory 
subunit that is thought to play a role in substrate recognition and recruitment. In 
addition to the canonical regulatory subunit family which consists of ~15 genes, a host 
of other proteins have been reported to interact with PP2A, modulating its activity 
(Goudreault et al., 2009; Herzog et al., 2012). The PP2A complex is tightly regulated 
at every stage, from transcription and translation of its individual complex components 
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to post translational modifications that may regulate phosphatase complex stability 
and assembly (Janssens et al., 2008).  
 
In this study, I look into the regulation of PP2A activity on ULK1 during starvation- 
induced autophagy. Under fed conditions the PP2A catalytic subunit is sequestered by 
inhibitory protein Alpha4, keeping it in an inactive state. Starvation triggers the 
release of PP2A from this latent complex, while Torin1 treatment does not, correlating 
with faster dephosphorylation of ULK1 and autophagy induction during starvation. In 
addition, I found that this phosphatase activity is abnormally high in Pancreatic Ductal 
Adenocarcinoma cell line 8988T, which requires high basal autophagy for optimal 
fitness. I propose that activation of the phosphatase activity toward ULK1 represents a 
mechanism that allows cancer cells to activate a strong autophagy flux without turning 
off mTORC1 activity, thus reaping the benefits of both. 
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4.2 Results  
Starvation activates phosphatase activity against ULK1 
It is well established that suppression of mTORC1 induces ULK1 complex dependent 
autophagy (Ganley et al., 2009; Jung et al., 2009). Given the central role of mTORC1 
in starvation-induced autophagy, it was puzzling to observe that starvation could 
induce a stronger autophagic response compared to pharmacological inhibition of 
mTORC1.  Mouse embryonic fibroblasts (MEFs) stably expressing GFP-LC3 formed 
clear puncta under both treatment conditions, indicating autophagy induction (Figure 
4.1 A). However, MEFs treated with starvation formed a larger number of GFP-LC3 
puncta and in a shorter time, indicating a stronger autophagy response. Supporting this 
observation, depletion of LC3 I as detected by western blotting was also more rapid in 
starvation treated cells, indicating efficient turnover of autophagosome contents 
(Figure 4.1 B).  
 
To gain better insight into this process, I compared the kinetics of ULK1 
dephosphorylation during starvation compared to pharmacological inhibition of 
mTORC1. As reported previously, ULK1 was rapidly dephosphorylated during 
starvation in MEFs, with nearly complete dephosphorylation at S637 and S757 within 
30 min of starvation (Figure 4.1 C). In contrast, a phospho-signal could still be 
detected after 30 min of treatment with rapamycin. Rapamycin functions as an indirect 
inhibitor of mTORC1, by binding to the 12-kD FK506-binding protein (FKBP12) and 
is therefore thought to be a weaker inhibitor compared to ATP competitive inhibitors 
of mTOR such as Torin1 (Benjamin et al., 2011; Thoreen et al., 2009). However, the 
same trend could be detected in cells treated with Torin1 compared to starvation 
(Figure 4.1 C), even though it could be observed at earlier time points that Torin1 
treatment was more effective at shutting down mTORC1 activity (Figure 4.1 D).  
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Phosphorylation events in a cell are regulated by a balance between kinase and 
phosphatase activities towards a substrate. As mTORC1 inactivation is insufficient to 
account for the rapid dephosphorylation and thereby activation of ULK1 during 
starvation, I hypothesized that starvation stimulates phosphatase activity toward 
ULK1. Consistent with this hypothesis, using ULK1 as a substrate, higher phosphatase 
activity could be detected in whole cell lysate from starved MEFs compared to MEFs 
in full media or rapamycin (Figure 4.1 E).  
 
Interestingly, under the conditions used to monitor ULK1 S637 dephosphorylation in 
vitro, ULK1 S757 was very inefficiently dephosphorylated (Figure 4.1 E). This could 
be interpreted in several ways: the phosphatase responsible for ULK1 S757 is not as 
abundant as PP2A, the S757 phosphatase is labile under the specific buffer conditions 
used in this assay, or the substrate due to the way it was prepared, lacks a co-factor or 
context (eg subcellular localization) required for recruiting the S757 phosphatase. 
Unfortunately, this precluded the possibility of purifying the S757 phosphatase 
through biochemical fractionation as we had done for PP2A-B55α (the S637 
phosphatase).   
 
A latent population of PP2A is activated during starvation  
How does starvation stimulate the activity of PP2A toward ULK1 S637? It is 
notoriously difficult to overexpress PP2AC due to the already high levels of 
endogenous PP2AC and tight regulatory control over PP2AC levels in the cell 
(Baharians and Schönthal, 1998). To isolate PP2AC complexes in the cell, I knocked  
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Figure 4.1 Amino acid starvation stimulates phosphatase activity for ULK1. 
(A, B) Starvation induces a stronger autophagic response than rapamycin. In (A), 
MEFs stably expressing GFP-LC3 were incubated in starvation media or treated 
with 1 µM rapamycin. Average number of puncta per cell was quantitated. (fold 
change ± s.d., n=30. two-tail student’s t-Test, * p<0.05). In (B), MEFs were lysed 
and immunoblotted for endogenous LC3 and other proteins. (C) Kinetics of mTOR 
substrate dephosphorylation. MEFs were incubated in starvation media or media 
containing 1 µM of either Torin1 or rapamycin. (D) Torin1 shuts down mTOR 
activity more efficiently than starvation. MEFs were incubated in starvation media 
or media containing 1 µM Torin1. (E) Starvation increases phosphatase activity for 
ULK1 S637 in MEFs. Upper panel shows a Schematic representation of the in vitro 
phosphatase assay. Middle panel shows outcome of the phosphatase assay 
comparing lysates from starved, fed or rapamycin treated cells. S-tag and total S6K 
are loading controls for the amount of substrate and enzyme, respectively. Lower 
panel shows quantitation of ULK1 S637 phosphorylation relative to time 0. (fold 
change ± s.d., n=4. two-tail student’s t-Test, * p<0.05). 
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down endogenous PP2AC in MEFs and replaced it with an shRNA resistant Flag-S 
doubly tagged PP2AC that was more convenient for experimental manipulation. Using 
this system, I was able to verify that PP2A complexes isolated from starved cells had 
higher activity against ULK1 (Figure 4.2).  
In yeast, Pph21 (PP2AC homologue) is regulated by Tap42 in a nutrient dependent 
manner (Di Como and Arndt, 1996). Tap42 is a highly conserved regulator of PP2AC 
with a mammalian homologue, Alpha4. It has been reported that Alpha4 is involved in 
mediating cell survival during glutamine starvation (Reid et al., 2013). While early 
studies suggested that Alpha4 may activate PP2A towards certain substrates (Chung et 
al., 1999), more recent studies indicate that PP2AC is inactive when bound to Alpha4 
(Jiang et al., 2013). To clarify the role of Alpha4 in PP2AC regulation, I co-expressed 
Alpha4 with PP2AC in an insect cell system and purified the recombinant protein 
complex. In an in vitro phosphatase assay, the recombinant PP2AC-Alpha4 complex 
could not dephosphorylate ULK1 (Figure 4.3 A and B). To further confirm that the 
Alpha4-containing PP2A complex is inactive in cells, I used a potent small molecule 
phosphatase inhibitor, microcystine-LR (MCLR) conjugated to agarose beads to 
isolate endogenous PP2AC complexes from WT MEFs. MCLR binds to the catalytic 
Figure 4.2 PP2A complexes from starved cells have higher phosphatase 
activity. MEFs stably expressing shRNA targeting the 3’UTR region of PP2AC 
were generated and reconstituted with Flag-S-PP2AC. Cells were incubated in full 
media or starvation media, lysed and incubated with Flag beads to pull down PP2A 
complexes. PP2A complexes were then titrated in a phosphatase assay against 
ULK1. 
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site of PP2AC when the enzyme is in an active conformation (Xing et al., 2006; Xu et 
al., 2006). Interestingly, the MCLR-beads pulled down PP2A holo-enzyme complexes 
containing the scaffolding (PRL65) and regulatory subunits (B55α was monitored as a 
representative regulatory subunit) but did not pull down PP2A complexes containing 
Alpha4, indicating that Alpha4-associated PP2AC is inactive in cells. This is in 
agreement with partial crystal structure data of PP2AC showing that the conformation 
of the catalytic site is greatly altered when PP2AC is bound to Alpha4 (Jiang et al., 
2013).  For comparison, Alpha4 interaction was easily detected when S-beads were 
used to pull down PP2AC in Flag-S-PP2AC reconstituted cells. (Figure 4.3 C).  
  
Figure 4.3 PP2A bound to Alpha4 is inactive. (A) Recombinant PP2AC-Alpha4 
complex is inactive. Phosphatase assay was carried out in vitro using increasing 
amounts of recombinant PP2AC (3-90 nM) co-purified with Alpha4. Recombinant 
PP2AC-PRL65 complex (20 nM) was used as a control. (B) Coomassie brilliant 
blue staining of recombinant PP2AC-Alpha4 used in the reaction. (C) Endogenous 
PP2AC-Alpha4 complex is catalytically inactive. WT MEFs (ctrl) were lysed and 
incubated with microcystin-LR (MCLR) beads which bind to the catalytic pocket 
of PP2AC. As a comparison, MEFs expressing Flag-S-PP2AC as described in 
figure 4.2 were lysed and incubated with S-beads to pull down total PP2A 
complexes in the cell.  
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To assess Alpha4 distribution among PP2AC complexes in the cell, I repeated part of 
the biochemical fractionation protocol used to identify B55α. MEF cell lysates were 
passed through a Q column followed by a HAP column which distributed PP2AC 
complexes across 9 fractions. Alpha4 was detected in fractions that had no activity 
against ULK1 and were separate from fractions containing B55α (Figure 4.4 A), 
supporting the idea that Alpha4 containing PP2AC complexes are a distinct population 
in the cell. PP2AC has been reported to bind Alpha4 and PRL65 in a mutually 
exclusive manner (Jiang et al., 2013; Prickett and Brautigan, 2004). To confirm this, I 
carried out immunoprecipitation reactions with B55α and Alpha4. Immuno-
precipitation of Alpha4 pulled down PP2AC but not PRL65 or B55α (Figure 4.4 B). 
Likewise immunoprecipitation of B55α (Figure 4.4 C) could pull down PRL65 and 
PP2AC but not Alpha4, indicating that they are in separate complexes (Figure 4.4 D).  
 
In yeast, the Pph21-Tap42 (PP2AC-Alpha4 homologues) interaction is sensitive to 
both nutrient deprivation and rapamycin treatment (Di Como and Arndt, 1996). I 
performed immunoprecipitation of endogenous PP2AC to check if the same was true 
in mammalian cells. Surprisingly, although starvation induced a clear decrease in the 
interaction of PP2AC with Alpha4, Torin1 treatment had no effect (Figure 4.5 A), 
indicating that regulation of the PP2AC-Alpha4 complex is different from yeast and 
independent of mTOR.  Notably, I could detect a concurrent increase in PP2AC 
association with PRL65 and B55α during starvation when crosslinking reagent DSP 
was used to stabilize the complex for immunoprecipitation (Figure 4.5B). This result 
indicates that starvation induces release of PP2AC from latent complexes containing 
Alpha4 to form active complexes containing PRL65 and regulatory subunits including 
B55α. As the starvation conditions used in my experiments thus far excluded both 
amino acids and serum, I wanted to clarify if it was amino acid or growth factor  
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Figure 4.4 PP2AC binds Alpha4 and PRL65 in a mutually exclusive manner. 
(A) Distribution of Alpha4 and regulatory subunit B55α among endogenous PP2A 
complexes. Cell lysate from ULK1/2 DKO MEFs were separated on a 
Hydroxyapatite column and assessed for activity against ULK1. (B) WT MEFs 
(ctrl) and MEFs stably expressing Flag-S-Alpha4 were incubated with S-Beads for 
immunoprecipitation. Western analysis was carried out to detect the presence of 
the indicated proteins. (C) WT HT1080 cells (ctrl) and HT1080 stably expressing 
Flag-S-B55α were incubated with S-Beads for immunoprecipitation. Western 
analysis was carried out to detect the presence of the indicated proteins. (D) 
Schematic of PP2AC complexes correlating with activity. "
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Figure 4.5 Starvation stimulates release of PP2A catalytic subunit from 
inhibitory protein Alpha4. (A) WT MEFs were incubated in starvation media or 
media containing 1 µM Torin1 for 1 hour, lysed and incubated with control antibody 
or antibody against PP2AC. The amount of Alpha4 interacting with PP2AC under 
each condition was monitored by Immunoblotting and quantitated on the right (fold 
change relative to full media ± s.d., n=5. two-tail student’s t-Test, * p<0.05). (B) 
Starvation induces dissociation of PP2AC from Alpha4. 293T cells were starved or 
incubated in complete media containing 1 µM Torin1 for 2 hr. Cell lysate was 
prepared, cross-linked with DSP and incubated with the indicated antibodies to pull 
down endogenous PP2A complexes for immunoblot analysis. Quantitation of co-
IPed proteins relative to full media is shown on the right. (fold change ± s.d., n=3. 
two-tail student’s t-Test, * p<0.05) 
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signaling that triggered alpha4 dissociation from PP2AC. Starvation media 
supplemented with dialysed serum still induced dissociation of Alpha4 from PP2A 
and serum starvation alone had no effect on PP2AC-Alpha4 interaction (Figure 4.6), 
confirming that the interaction was sensitive to amino acid levels.    
To further demonstrate that Alpha4 can affect the dynamics of active PP2A complex 
formation, we overexpressed Flag-S doubly tagged Alpha4 in 293T cells and assessed 
the effect on active PP2A complex formation by immune-precipitation of endogenous 
PP2AC. This experiment was carried out by Dr. Yan Feng, a postdoctoral fellow in 
our laboratory. Compared to control cells, less PRL65 co-immunoprecipitated with 
PP2AC in Alpha4 over-expressing cells (Figure 4.7 A). I also generated a stable MEF 
Figure 4.6 Amino acid but not serum starvation stimulates release of PP2A 
catalytic subunit from Alpha4. MEFs were incubated in starvation media (amino 
acid and serum free, AASF), complete media with 1 µM Torin1 (T), amino acid 
free media supplemented with 10% dialysed FBS (AAF), or serum free media 
(SS). Cells were lysed and incubated with control antibody or antibody against 
PP2AC. The amount of Alpha4 interacting with PP2AC under each condition was 
monitored by immunoblotting and quantitated on the right (fold change relative to 
full media ± s.d., n=3) 
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cell line overexpressing Alpha4 in order to assess if this has any functional 
consequence on starvation-induced ULK1 dephosphorylation. Overexpression of 
Alpha4 reduced the rate of dephosphorylation at ULK1 S637, consistent with its role 
as a negative regulator of PP2A activity (Figure 4.7 B). In agreement with earlier 
observations, dephosphorylation at S757 was not affected by Alpha4 overexpression. I 
was unable to do the converse experiment by RNAi as knockdown of Alpha4 results 
in depletion of PP2AC expression and cell death, as reported previously (Kong et al., 
2004). 
“Autophagy-addicted” cells have high basal levels of phosphatase activity 
During nutrient starvation, PP2A phosphatase is activated with concurrent inactivation 
of the kinase phosphorylating ULK1 (mTORC1), resulting in a rapid and strong 
induction of autophagy. To follow up with my observation that PP2A is activated 
independently of mTORC1, I searched for a biological context in which the 
Figure 4.7 Alpha4 overexpression reduces PP2A activity. (A) Alpha4 
overexpression reduces PRL65 binding to PP2AC. 293T cells were transfected with 
Flag-S-Alpha4. Cells were lysed, and incubated with antibodies to pull down 
endogenous PP2AC. Immunoblotting was carried out to monitor the amount of 
PRL65 interacting with PP2AC. (B) Alpha4 overexpression blocks ULK1 S637 
dephosphorylation. MEF cells stably overexpressing Flag-S-Alpha4 were incubated 
in complete or starvation media for the indicated amount of time. Panel A was 
carried out by Dr. Yan Feng. 
 74"
phosphatase might influence ULK1 activation and autophagy independent of 
mTORC1 activity.  
 
Recent reports indicate that some cancers, in particular pancreatic cancers carrying 
Ras mutations are “addicted” to autophagy, requiring high basal autophagy levels in 
order to maintain viability and growth (Guo et al., 2011; Guo et al., 2013; Yang et al., 
2011). It is unclear as to how these “autophagy addicted” cell lines are able to 
maintain high levels of autophagy in the absence of mTORC1 inactivation since 
mTORC1 activity is generally thought to suppress autophagy by inhibiting the ULK1 
complex. One possibility is that ULK1-independent mechanisms may be driving 
autophagy in these cells, but an alternate hypothesis is that signaling through the PP2A 
phosphatase pathway may be driving ULK1-dependent autophagy while maintaining 
mTORC1 function intact. As shown in Figure 4.8 A, cell lysates of pancreatic ductal 
adenocarcinoma (PDAC) cell lines BXPC3 and 8988T had significantly higher 
phosphatase activity toward ULK1 S637 site compared to control cancer cell lines 
U2OS (osteosarcoma) and H460 (non-small cell lung cancer) that are not “addicted” 
to autophagy. Interestingly, I detected higher expression of regulatory subunit B55α in 
BXPC3 cells and lower levels of Alpha4 in 8988T cells (Figure 4.8 B), correlating 
with the high phosphatase activity against ULK1 in these cell lines. 
 
I confirmed high basal levels of autophagy in these cell lines using two complimentary 
assays. In the first assay, I treated cells with bafilomycin to block degradation of LC3 
and observed more dramatic accumulation of LC3 form II in the two PDAC cell lines 
(Figure 4.8 C and D).  In the second assay, I blocked synthesis of new LC3 using 
translational inhibitor cycloheximide and tracked the degradation of existing LC3 over 
time. A significantly faster rate of LC3 turnover was detected in both PDAC cell lines  
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Figure 4.8 Phosphatase activity correlates with high basal levels of autophagy 
in pancreatic ductal adenocarcinoma cell lines. (A) Pancreatic ductal 
adenocarcinoma (PDAC) cell lines have high phosphatase activity. In vitro 
phosphatase assay was carried out using Flag-S-ULK1 as a substrate and 10 µg of 
total cell lysates from indicated cancer cell lines.  (B) Immunoblot for endogenous 
levels of PP2A regulatory proteins B55α and Alpha4 in control cell line H460 and 
PDAC cell lines BXPC3 and 8988T. (C-F) PDAC cell lines have high basal 
autophagy. In (C), cell lines were kept in complete media in the presence or absence 
of 20 nM bafilomycin (Baf) for 90 min and lysed for immunoblotting of 
endogenous LC3. In (D), Cell lines stably expressing GFP-LC3 were kept in 
complete media in the presence or absence of 20 nM bafilomycin (Baf) for 90 min. 
In (E, F) cells were kept in complete media with 20 µg/ml cycloheximide (CHX) for 
the indicated amount of time. Where indicated, 10 nM bafilomycin was added at the 
start of CHX treatment. Cells were lysed and immunoblotted for endogenous LC3. 
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compared to control cell line H460 (Figures 4.8 E and F). The LC3 turnover in both 
cell lines could be blocked by the addition of bafilomycin, consistent with degradation 
occurring through the autophagosome-lysosome pathway. Importantly, mTORC1 
remained active during the course of cycloheximide treatment (Figures 4.8 E, F and 
Figure 4.9 C and D), indicating that basal autophagy in these cell lines was occurring 
independent of mTOR inactivation.  
 
Subsequently, I confirmed that both PP2A activity and the ULK1 complex are 
required for high basal autophagy in PDAC cell line 8988T. Treatment with OA or 
knockdown of PP2AC blocked basal turnover of LC3 (Figure 4.9 A and B). The same 
result was achieved when ULK1 complex components (either ULK1 or FIP200) were 
knocked down (Figure 4.9 C and D). Furthermore, knockdown of ULK1 reduced 
proliferation and anchorage-independent growth of 8988T cells (Figure 4.10 A and B), 
supporting previous reports that disrupting basal autophagy has a functional 
consequence on the fitness of PDAC cells such as 8988T (Yang et al., 2011).  As a 
control, knockdown of ULK1 had no effect on “non-addicted” cancer cell line H460 
(Figure 4.10 A and B). Hence, high PP2A activity can drive basal autophagy in an 
mTOR-independent manner through regulation of the ULK1 complex, contributing to 
robust growth of “autophagy-addicted” cancer cells (Figure 4.11).  
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Figure 4.9 PP2AC and the ULK1 complex are required for basal turnover of 
LC3 in 8988T cells. (A) PDAC cell line 8988T was kept in complete media with 
20 µg/ml cycloheximide (CHX) for 4 hrs. Where indicated, 10 nM Baf was added 
at the start of CHX treatment. To assess phosphatase involvement, cells were 
pretreated with 200 nM okadaic acid (OA) in full media for 2 hours and removed 
at the start of CHX treatment. (B) 8988T was transduced with control siRNA or 
siRNA targeting the catalytic subunit of PP2A. Cells were kept in complete media 
with 20 µg/ml cycloheximide (CHX) for the indicated amount of time and 
immunoblotted for endogenous LC3. (C) 8988T cells were transduced with 
control shRNA or shRNA targeting ULK1. Cells were treated as in (B). (D) 8988T 
was transduced with control siRNA or siRNA targeting FIP200. Cells were treated 
as in (B). * denotes non-specific band."
 78"
 
  
Figure 4.10 The ULK1 complex is required for robust growth of PDAC cell 
line 8988T. (A) Equal number of 8988T or H460 cells stably expressing control 
shRNA or shRNA targeting ULK1 were seeded on Day 0. Upper panel shows cells 
fixed and stained with crystal violet on Day 1 and Day 4 respectively. Histograms 
on the lower panel show quantitation of crystal violet stain over time, relative to 
Day 0. Error bars are standard deviation from triplicates. (B) ULK1 complex is 
required for sustained anchorage-independent growth of 8988T. Cell lines in (A) 
were used in a soft agar assay. Representative images and knockdown efficiencies 
are shown. Histogram shows quantitation of colonies in each cell line relative to 
control shRNA. (relative colony number ± s.d., n=3. two-tail student’s t-Test, ** 
p<0.01)  "
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Figure 4.11 Schematic representation of PP2A signaling to the ULK1 
complex. In normal cells, PP2A activity is low under nutrient rich conditions. 
Amino acid starvation induces release of PP2A catalytic subunit from latent 
complexes containing Alpha4 for incorporation into active complexes containing 
the scaffolding subunit PRL65 and regulatory subunits such as B55α, resulting in 
a stimulation of PP2A activity. This dissociation event is not regulated by 
mTOR. “Autophagy-addicted” cancer cells are able to maintain high 
phosphatase activity to drive ULK1-dependent autophagy even in the absence of 
mTOR inactivation, allowing them to reap the dual benefits of mTOR activation 
and autophagy at the same time.  
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4.3 Discussion 
Several kinases have been reported to regulate autophagy, including mTOR (Chan, 
2009), AMPK (Egan et al., 2011), PKA (Cherra et al., 2010), STK3/STK4 (Wilkinson 
et al., 2015) and DAPK (Zalckvar et al., 2009). In contrast, the role of phosphatases in 
this process has rarely been broached. It is known that mTOR directly phosphorylates 
ULK1 under nutrient rich conditions and it is generally thought that mTOR 
phosphorylation of ULK1 keeps its activity low under conditions of amino acid 
sufficiency (Hara et al., 2008). In this study we shed light on the phosphatases that 
regulate ULK1 during starvation-induced autophagy. Inhibition of mTOR by 
rapamycin or Torin1 treatment is sufficient to result in ULK1 dephosphorylation and 
autophagy induction, indicating that basal levels of phosphatase activity are always 
present in the cell. What was remarkable to me was that ULK1 dephosphorylation at 
both S637 and S757 was more rapid during starvation compared to Torin1/ rapamycin 
treatment, suggesting that starvation could stimulate phosphatase activity. Importantly, 
the increased phosphatase activity correlated with a stronger autophagy response 
elicited by starvation compared to rapamycin treatment, indicating that the 
phosphatases regulating ULK1 could be another signaling node for regulating 
autophagy. 
 
Having identified PP2A to be the phosphatase regulating ULK1 at S637, I attempted 
to elucidate the mechanism behind PP2A activity stimulation during starvation. 
PP2AC is one of the most abundant phosphatase catalytic subunits in the cell and is 
controlled by complex regulatory mechanisms at several levels. Aside from the 
scaffolding and regulatory subunits, a number of other proteins such as PP2A 
Inhibitor-1 (I1PP2Aaka PHAP-I or ANP32a) and Inhibitor-2 (I2PP2Aaka SET or PHAP-
II) (Li et al., 1995), Cancerous Inhibitor of PP2A (CIP2A) (Junttila et al., 2007), 
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methyl esterase PME-1 (Ogris et al., 1999) and Alpha4 (Kong et al., 2004) have been 
reported to bind PP2AC directly and affect its activity. I was interested in Alpha4 in 
particular due to previous reports in yeast that its interaction with PP2AC is nutrient 
dependent (Di Como and Arndt, 1996). 
 
To my knowledge, the detection of free PP2A catalytic subunits in the cell has not 
been reported. When detected, it is either in complex with its scaffolding subunit 
PRL65 or another binding partner that can modulate its activity. It is likely that free 
PP2AC is rapidly turned over to prevent unchecked phosphatase activity in the cell 
(Virshup and Shenolikar, 2009). In agreement with recent reports, I found PP2AC 
bound to Alpha4 to be catalytically inactive in vitro. Fractionation of PP2A complexes 
from the cell also showed Alpha4 to be associated with inactive PP2A complexes and 
is distinct from active B55α- containing complexes. While my fractionation data 
suggests that only a sub-population of PP2AC is associated with Alpha4, it is an 
essential regulator of PP2AC. Knocking out Alpha4 in a conditional mouse model 
results in a concurrent depletion in type 2 phosphatase levels (PP2AC, PP4C, PP6C), 
rapidly resulting in cell death (Kong et al., 2009). Supporting the role of Alpha4 in 
maintaining PP2AC stability, overexpression of Alpha4 suppresses PP2AC 
polyubiquitination (McConnell et al., 2010). The drastic phenotype of knocking out 
Alpha4 supports the idea that it has a fundamental “chaperone-like” role in 
maintaining cellular pools of PP2AC (Kong et al., 2009), in contrast to other PP2AC 
binding partners such as PME-1, whose function is more regulatory in nature. PP2AC 
levels are not as drastically perturbed in PME-1-/- mice, which show a moderate 
reduction in PP2AC levels only in some tissues and have no gross defects 
developmentally but die within the first day of birth (Ortega-Gutiérrez et al., 2008). 
This has led to a model of “latent stability” where Alpha4 binds PP2AC keeping it 
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stable but inactive until it is required for incorporation into active complexes 
containing the scaffolding and regulatory subunits. How the assembly of active PP2A 
complexes is co-ordinated remains unclear and may involve other proteins that 
incorporate post-translational modifications in the highly conserved C-terminal tail of 
PP2AC (Janssens et al., 2008; Sents et al., 2013). 
 
In yeast, interaction between PP2AC and Tap42 (the yeast counterpart of Alpha4) is 
dramatically disrupted by rapamycin treatment (Di Como and Arndt, 1996), indicating 
that TOR inactivation is sufficient to stimulate PP2A activity in yeast. Tap42 was also 
shown to be a direct substrate of TOR, leading to a model in which TOR regulated 
PP2AC-Tap42 interaction through phosphorylation of Tap42 (Jiang and Broach, 
1999). In my hands starvation was a much stronger trigger for Alpha4 dissociation 
from PP2AC compared to Torin1 treatment, indicating that PP2AC regulation is 
different and likely more complex in mammalian cells. This difference could account 
for the observation that ULK1 dephosphorylation occurs more rapidly in starvation 
compared to Torin1 inhibition of mTOR and supports the hypothesis that the PP2A 
phosphatase represents a separate pathway feeding into autophagy activation.  
 
This finding has some implications in cancer biology. mTOR plays a fundamental role 
in regulating cell growth through controlling translation and ribosomal biogenesis. The 
oncogenic PI3K/AKT pathway exerts its effects primarily through mTORC1 (Guertin 
and Sabatini, 2007), making it an attractive target for cancer treatment. On the other 
hand, it has been proposed that autophagy (which is inhibited by mTORC1) can 
support cancer growth by alleviating metabolic stress (Kimmelman, 2011; Leone and 
Amaravadi, 2013). In line with this, knockdown of autophagy related genes has also 
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been shown to impact tumor growth in several cancer models (Guo et al., 2011; Rao et 
al., 2014; Wei et al., 2011).  
 
In this study, I observed that high phosphatase activity is correlated to high basal 
levels of autophagy in 2 pancreatic cancer cell lines (BxPC3 and 8988T) that were 
previously reported to be “autophagy-addicted”. Depletion of PP2A or members of the 
ULK1 complex impaired the basal rate of autophagy, suggesting that high phosphatase 
activity drives ULK1-dependent autophagy in these cell lines. Activation of the 
protein phosphatase targeting ULK1 can explain the seemingly contradictory co-
existence of intact mTORC1 signaling and autophagy activity in various cancers.  
 
While I have shown that both PP2A and ULK1 are required for the high basal 
autophagy, the exact phosphorylation events involved are unclear. Ideally, this should 
be worked out through the use of phospho-mimetic mutants, however phospho-
mimetic mutants of ULK1 that block autophagy have not yet been reported despite 
multiple groups having mapped phosphorylation sites on ULK1. Personally I have 
also tried S637D and S757D mutants, but they did not block autophagy induction. 
This may be a purely technical issue, in that phospho mimetic mutations do not always 
effectively recapitulate a phosphorylation event. It may also indicate that mutations on 
2 residues is insufficient to affect a protein that is not only phosphorylated on multiple 
sites but is part of a complex containing other proteins (ATG13 and FIP200) that are 
also phosphorylated.  
 
The mechanisms driving phosphatase activity in 8988T and BxPC3 are also unclear. I 
detect higher levels of B55α in BxPC3 and lower levels of Alpha4 expression in 
8988T, correlating with higher phosphatase activity in these cell lines. What controls 
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the levels of these proteins and whether the same mechanism is in play in both cell 
lines is unknown. Based on our current understanding of Alpha4 function, the lower 
levels of Alpha4 may not be causative but simply reflect the higher phosphatase 
activity in 8988T. 
 
 In summary, the data presented here supports an interesting model in which the 
deregulation of PP2A activity may be an avenue through which cancer cells 
simultaneously reap the benefits of both mTORC1 signaling and autophagy activation. 
It also provides a preliminary indication that ULK1 may be a viable therapeutic target 
for some cancers. Further experiments in mouse models would better support this as 
the physiological environment in vivo is much more complex.  
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4.4 Experimental Procedures 
Reagents & Antibodies 
For antibody information, please refer to experimental procedures in Chapter 3. 
Rapamycin was purchased from Enzo Life sciences (A-275). Torin1 was purchased 
from Tocris Bioscience. Okadaic acid was purchased from Sigma (O9381) or Enzo 
Life sciences (ALX-350-003) with each showing identical effects on ULK1 
dephosphorylation.  Cycloheximide was purchased from Calbiochem (239-763) and 
Bafilomycin A1 (B1793) was purchased from Sigma.  
 
Cell culture  
HT1080, and 8988T cell lines were cultured in Dulbecco’s Modified Eagles Media 
(DMEM), supplemented with 10% fetal bovine serum, 2 mM L-Glutamine and 1X 
penicillin-streptomycin at 37°C, 5% CO2. H460 and BXPC3 cell lines were grown in 
RPMI Media, supplemented with 10% fetal bovine serum, 2 mM L-Glutamine and 1x 
penicillin-streptomycin.  H460 and 8988T cell lines were a kind gift from Dr. Alec 
Kimmelman, Dana Farber Cancer Institute, Boston, USA. Stable expression of 
transgenes such as Flag-S-Alpha4 and Flag-S-PP2AC or shRNA cassettes were 
carried out by retroviral or lentiviral transduction.  
 
Treatment conditions and cell lysis 
For amino acid starvation experiments, cells were washed twice and incubated in 
DMEM lacking amino acids and serum for the indicated amount of time. Rapamycin 
and Torin1 treatments to inhibit mTOR activity were both done at a final 
concentration of 1 µM in complete media.  To assess basal autophagy, a 
cycloheximide chase experiment was carried out. Cells were treated with translational 
inhibitor cycloheximide  (used at a final concentration of 20 µg/ml in complete media) 
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to block synthesis of nascent LC3. Turnover of existing LC3 was tracked over time by 
SDS-PAGE analysis. Lysosomal inhibitor Bafilomycin A1 was used at a final 
concentration of 10 nM or 20 nM as indicated to assess autophagy flux.    
 
All samples prepared solely for western analysis were lysed in RIPA buffer (50 mM 
Tris pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% 
sodium dodecyl sulfate) supplemented with protease inhibitors and phosphatase 
inhibitors (P0044 and P5726 from Sigma). Protein concentration was determined 
using Bio-Rad Protein Assay Dye reagent (#500-0006). 
 
Fluorescence microscopy 
Fluorescence microscopy was carried out as in Chapter 3. 
 
In vitro dephosphorylation assay 
For phosphatase assays with cell lysate: Flag-S-ULK1 substrate was incubated with 10 
µg of total cell lysate at 30oC for the indicated amount of time. For phosphatase assays 
with recombinant proteins: Flag-S-ULK1 substrate plus 7-10 µg of phosphatase-
depleted protective lysate was incubated with recombinant proteins at 30oC for 20 
min.  
 
Purification of recombinant proteins 
Full length mouse Alpha4 (NM_008784) was cloned into pFastBac as N-terminal 9x 
His and Flag tandem-tagged proteins. Recombinant baculovirus was produced using 
Bac-to-Bac expression system from Invitrogen. PP2AC and Alpha4 were co-expressed 
in a suspension culture of Sf9 cells for co-purification. Cell pellets were lysed by 
douncing and purified by Ni-NTA resin, followed by incubation with Anti-Flag M2 
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affinity gel (A2220 from Sigma) at 4oC for 5 hrs. PP2AC bound to Alpha4 was eluted 
with 3x Flag peptide and assayed for activity immediately.  
 
Knockdown by shRNA or siRNA 
The following shRNA constructs were purchased from Sigma: pLKO hULK1 shRNA 
(GCCCTTTGCGTTATATTGT AT). The following shRNAs were cloned into 
pLKOtet-ON inducible shRNA plasmid system purchased from Addgene: mPP2AC 
shRNA (GCGACATTGTTGGTCAAGAAT). Lenti- viruses were made by co-
transfecting shRNA constructs and packaging vectors into 293Ts. Lentiviral 
preparations were passed through a 0.45 µM PES filter and supplemented with 
polybrene before being used to transduce cells. Stable cell lines were typically assayed 
for knockdown 48-72 hours post transduction. For inducible knockdown, cell lines 
were grown in complete media containing 100 ng/ml Doxycycline 48-72 hours before 
assaying for knockdown. 
 
For knockdown by siRNA, siGENOME Control siRNA (D-001210-05-20) and 
siGENOME SMARTpool FIP200 (RB1CC1) siRNA (M-021117-01) were purchased 
from Dharmacon. siRNAs were transfected into cells at a final concentration of 100 
nM with 2 µl Lipofectamine 2000 (Invitrogen) as per manufecturer’s protocol. Cells 
were assayed 48 hrs after transfection. 
 
Expression constructs 
The coding sequence (cds) of human PRL65 or mouse Alpha4 were cloned into pMIC 
vector along with an N-terminal Flag-S tandem tag. PRL65 was also cloned into 
pBabe-Flag-S (puro) vector. 
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Immunoprecipitations 
For pull down of Flag-S-PP2A complexes: Following treatment, Flag-S-PP2AC 
expressing cells were washed twice in cold PBS(-) and lysed in IP buffer 
supplemented with protease inhibitors. Cell lysate was centrifuged at 20,000 x g for 10 
min at 4oC. Protein concentration of clarified cell lysate was determined by Bio-Rad 
Protein Assay Dye reagent. An equal amount of clarified cell lysate from each 
treatment condition was incubated with 10 µl of S-protein agarose beads (69704 from 
EMD Millipore) for 4 hours at 4oC with rotation. For IP with MCLR beads (16-147 
from EMD Millipore), cells were washed twice in cold PBS(-) and lysed in IP buffer 
supplemented with protease inhibitors. Cell lysate was centrifuged at 20,000 x g for 10 
min at 4oC. 500 µg of clarified cell lysate was incubated with 10 µl of MCLR beads 
for 4 hours at 4oC with rotation. In all cases, beads were then washed 5 times in IP 
buffer before elution in SDS-loading dye and analysis by SDS-PAGE. 
 
For pull down of endogenous PP2A complexes: Following treatment, cells were 
washed twice in cold PBS(-) and lysed in KCl-IP buffer (20 mM Tris pH 7.5, 100 mM 
KCl, 0.5 mM DTT, 0.2% NP-40, 10% glycerol) supplemented with protease 
inhibitors. Cell lysate was centrifuged at 20,000 x g for 10 min at 4oC. Protein 
concentration was measured. An equal amount of clarified cell lysate from each 
treatment condition (500 mg-1mg) was incubated with 0.6-1 ml of Mouse anti-PP2AC 
antibody (clone 1D6 #05-421 from Millipore) at 4oC with rotation overnight. Lysates 
were then incubated with Protein G agarose for 3 hrs at 4oC with rotation. For 293Ts 
overexpressing Alpha4, PP2A IP was carried out 48 hrs post transfection. 
 
For DSP (Lomant’s reagent, Thermo Scientific #22585) crosslinking in 293T cells: 
Cells were grown in 10-cm dishes, treated and lysed in 1 ml DSP-IP buffer (20 mM 
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Hepes pH 7.5, 100 mM KCl, 1 mM Mn2+, 0.1% NP-40) supplemented with protease 
inhibitors. Cell lysate was centrifuged at 20,000 x g for 10 min at 4oC. 1 ml of 
clarified cell lysate was gently added to 4 ml of crosslinking reagent DSP (125 mg/ml 
stock in DMSO) to make a final concentration of 0.5 mg/ml DSP. This was rotated at 
room temperature for 4 min. Reaction was quenched by the addition of 25 ml of 1 M 
Tris pH 7.5. Lysates were then centrifuged at 20,000 x g for 10 min at 4oC to remove 
any precipitated DSP. Protein concentration of clarified lysates was measured. 1 mg 
crosslinked cell lysate was incubated with 1 ml anti-PP2AC antibody (clone 1D6) and 
immunoprecipitation was carried out as described above. Crosslinking was reversed 
prior to gel run by boiling samples 3 x 10-min in SDS-loading dye supplemented with 
additional β-mercaptoethanol (25% V/V). After gel run, PAGE gel was rinsed in 
transfer buffer for 15-30 min prior to transfer. 
 
Cell growth assay 
Cells were plated onto a 12 well plate in triplicate at 15’000 cells per well. The day 
after plating was considered day 0. Cells were fixed in 10% formalin for 10 min and 
stained with 0.1% crystal violet for 20 min. Excess dye was removed by washing 3 
times with water. Stained cells were left to air dry before dye was extracted with 10% 
acetic acid. Relative proliferation was determined by measuring absorbance at 570 nm.     
 
Soft agar assay 
Soft agar assay was carried out in 6 well plates in triplicate for each cell line. An 
underlay of 2 ml media with 0.5% agar (2-Hydroxyethylagarose, Sigma A4018) was 
dispensed into each well and allowed to set. Cells were resuspended in media 
containing 0.4% agar and seeded at 5000 cells per well in a volume of 1.5 ml. After 10 
to 14 days, colonies were stained with iodonitrotetrazolium chloride (Sigma, I10406) 
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and visualized with GELCOUNT™ imaging system (Oxford Optronix). Total colony 
number for each well was enumerated based on colony size and staining intensity.   
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CHAPTER 5. PERSPECTIVES 
 
mTOR signaling to the ULK1 complex 
The ULK1 complex integrates signaling inputs from several sources (Figure 1.3), and 
is a direct substrate of mTORC1. In this dissertation, I compared the rate of ULK1 
dephosphorylation and autophagy induction during starvation versus pharmacological 
inhibition of mTOR by rapamycin or Torin1 treatment. Interestingly, I observed 
differences even between the two mTOR inhibitors used. Although both rapamycin 
and Torin1 treatment result in S6K dephosphorylation, rapamycin treatment resulted 
in slower ULK1 dephosphorylation and autophagy induction. While Torin1 binds 
directly to the catalytic site of mTOR and thus inhibits both mTORC1 and mTORC2, 
rapamycin inhibits mTOR in an allosteric manner by binding to FKBP12 and is 
largely specific to mTORC1 though there have been reports that assembly of the 
mTORC2 complex may be inhibited as well in some cell types during prolonged 
rapamycin treatment (Sarbassov et al., 2006). The effects of rapamycin on mTOR 
signaling is complex, and may be cell line specific, with some groups reporting that 
certain functions of mTORC1 are resistant to inhibition by rapamycin (Choo et al., 
2008; Feldman et al., 2009; Thoreen et al., 2009). Given the difference in rate of 
dephosphorylation of ULK1 between the two conditions (Torin1 versus rapamycin 
treatment) and since neither condition results in PP2A activation, perhaps ULK1 
dephosphorylation is one of the rapamycin-resistant functions of mTORC1. Another 
way to account for the difference is that Torin1 inhibits mTORC2 as well, which can 
feed into the mTORC1 pathway through AKT (Figure 5.1).   
 
The starvation conditions used in my studies deprives cells both of amino acids as well 
as growth factors, resulting in dephosphorylation of both S6K and AKT after one hour  
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Figure 5.1 Schematic representation of mTOR and phosphatase signaling to 
the ULK1 complex. Growth factor and amino acids regulate ULK1 complex 
activity through the mTOR complexes and phosphatases. Under nutrient rich 
conditions, mTORC1 phosphorylates ULK1 at several sites, including S637 and 
S757. Growth factor and amino acid starvation inactivates the mTOR complexes 
and stimulates phosphatase activity toward ULK1. Assembly of the PP2A-B55a 
complex is stimulated by amino acid signaling and dephosphorylates ULK1 at 
S637. Dephosphorylation of ULK1 at S757 is mediated by an unknown 
phosphatase.  
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of starvation and indicating an inactivation of both mTORC1 and mTORC2. Despite 
withdrawal of both amino acids and growth factors, Torin1 treatment was more 
effective in shutting down mTORC1 compared to starvation (as monitored by S6K 
phosphorylation status), possibly indicating that it is rapidly cell permeable and binds 
to the catalytic subunit with high affinity. For a more complete picture of mTORC1 
status, other mTORC1 substrates such as 4EBP1 and the phosphorylation status of 
mTOR itself should be monitored. Even though Torin1 appears to shut down 
mTORC1 more rapidly, starvation induced faster dephosphorylation of ULK1, 
supporting our initial hypothesis of phosphatase activity stimulation during starvation.  
 
The second ULK1 phosphatase 
In the third chapter of this dissertation, I describe the characterization of ULK1 
dephosphorylation during starvation and identify the phosphatase targeting ULK1 
S637 dephosphorylation to be Protein Phosphatase 2A (PP2A). Blocking PP2A 
activity in cells blocked dephosphorylation of S637 but did not block 
dephosphorylation of ULK1 at a second site, S757. Likewise in an in vitro assay,  
recombinant PP2A dephosphorylated ULK1 at S637 but had no effect on S757, 
indicating that a second phosphatase is involved in the regulation of ULK1.  
 
To date, two groups have published targeted siRNA screens attempting to identify 
protein phosphatases involved in autophagy regulation, but with limited success 
(Martin et al., 2011; Puustinen et al., 2014).  With the number of phosphorylation 
events that have been reported throughout the autophagy pathway (ULK1, ATG13, 
Beclin-1, VPS34, LC3, p62 etc), this would seem unusual. The lack of hits identified 
in the two screens could be due to many reasons, the siRNA knockdown efficiencies 
were not monitored hence it is unclear if the phosphatases tested were not involved in 
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autophagy or were not sufficiently depleted to show a phenotype. It is also possible 
that the relevant phosphatases are completely novel and hence not included in the 
siRNA library. I have also tried an siRNA approach specifically to identify the second 
ULK1 phosphatase, but without success. Perhaps the best way to identify the second 
ULK1 phosphatase is still through biochemical purification, which can be combined 
with sub cellular fractionation to expand the searchable space from soluble proteins to 
include membrane proteins as well.    
 
Phosphatase regulation of the ULK1 complex 
The significance of having an mTORC1 independent signaling input (PP2A-B55α) to 
the ULK1 complex and the significance of having more than one phosphatase regulate 
the ULK1 complex is unclear but would certainly allow for greater control over ULK1 
function. Previously our understanding of the ULK1 complex was very much framed 
by the observation that it is a direct substrate of mTORC1, placing it as an initiator 
complex with a role in mediating amino acid starvation. However, there are an 
increasing number of reports suggesting that ULK1 can influence downstream events 
in autophagy (Lim et al., 2015) and can play a role in other types of autophagy (e.g. 
mitophagy (Wu et al., 2014) and xenophagy (Kageyama et al., 2011)) that may or may 
not involve mTOR inactivation.  As our understanding of ULK1 complex function 
expands beyond its role as merely an initiator of starvation-induced autophagy, 
different groups of phosphorylation events on ULK1, or the balance between the 
kinases and phosphatases regulating these sites may provide a handle for modulating 
ULK1 function between these roles. To address this possibility, we would first need to 
identify ULK1 dependent forms of autophagy that do not involve mTORC1 
inactivation and determine the requirement of phosphatase activity in those contexts.       
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Previously it was reported that long mTORC1 is reactivated during prolonged 
starvation (Yu et al., 2010). The significance of this is not known. It is speculated that 
the reactivation of mTORC1 may be to limit the catabolic effects of autophagy or 
could be to reactivate some anabolic processes governed by mTORC1 such as protein 
and lipid synthesis for cellular maintenance during prolonged periods of starvation. 
Perhaps signaling input from the phosphatase can keep ULK1 and hence some levels 
of autophagy active during mTORC1 reactivation, thereby continuing to provide a 
steady source of biological material to sustain anabolic processes. In light of this, it 
would be interesting to carry out a time course for phosphatase activity (or ULK1 
phosphorylation status) to see if there is an inverse relationship with mTOR activity 
status (eg. is there a further increase in phosphatase activity when mTORC1 is re-
activated?). Alternatively, the PP2AC-Alpha4 interaction could be monitored as well.  
 
PP2AC-Alpha4 interaction 
Protein phosphatases are certainly an interesting and under-studied group of proteins, 
and we are only now beginning to appreciate some of the complex mechanisms that 
regulate their function. In this dissertation, I was able to show that starvation induces 
dissociation of PP2AC from Alpha4 and this interaction is not regulated by mTORC1 
as Torin1 treatment did not induce dissociation of the complex. The mechanism 
regulating PP2AC-Alpha4 interaction is an interesting question that remains 
unanswered in this study. I would speculate that what lies upstream of the PP2AC-
Alpha4 interaction points to a novel amino acid sensing mechanism in the cell that 
may or may not also feed into mTORC1 signaling (Figure 5.1). Over the years, much 
work has been done on amino acid sensing by mTORC1, resulting in a model whereby 
Rheb (Garami et al., 2003; Inoki et al., 2002) and Rag GTPases (Sancak et al., 2008; 
Sancak and Sabatini, 2009) co-ordinately regulate mTORC1 activation in response to 
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growth factor and amino acid levels respectively. More players in this pathway have 
since been reported (Bar-Peled et al., 2012; Peterson et al., 2009; Sancak et al., 2010; 
Wang et al., 2015), yet our understanding of amino acid sensing in the cell remains far 
from complete. Studying the PP2AC-Alpha4 interaction may allow us to uncover 
more players involved in amino acid sensing in the cell.  
 
mTORC1 is reported to be particularly responsive to levels of Leucine and Arginine in 
the cell, in that addition of these amino acids alone is sufficient to re-activate 
mTORC1 after starvation (Hara et al., 1998; Sancak et al., 2008). In support of this, 
lysosomal Arginine transporter SLC38A9 (Wang et al., 2015) and Leucyl-tRNA 
synthetase (Han et al., 2012) were shown to regulate mTORC1. Overnight glutamine 
starvation (24 hours) has been reported to induce Alpha4 dissociation from PP2AC. 
While short (1 – 2 hours) timepoints were used to monitor PP2AC-Alpha4 interaction 
in my study, glutamine starvation might be a good starting point to find upstream 
regulators of PP2AC-Alpha4 that differentiate it from mTORC1 signaling. Recently it 
was reported that cells can reactivate mTORC1 in response to Glutamine as well, but 
the effect was observed in cells lacking Rag GTPases (thus no longer responsive to 
Leucine and Arginine) (Jewell et al., 2015), arguing that Glutamine signaling may not 
have a major effect on mTORC1 in cells with intact Rag function.  
 
ULK1 as a target for cancer treatment 
Based on mouse models and work in cancer cell lines, several groups have proposed 
targeting autophagy for cancer treatment (Kimmelman, 2011; Leone and Amaravadi, 
2013). Currently, small molecule inhibitors used to block autophagy include 
bafilomycin, chloroquine, and hydroxychloroquine, which target the lysosomes- the 
endpoint of autophagy; wortmannin, 3-Methyladenine and LY294002, which target 
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PI3Ks, including class III PI3K VPS34- whose activity is required for autophagy. 
Efforts have been made to develop more specific VPS34 inhibitors (Bago et al., 2014; 
Dowdle et al., 2014; Ronan et al., 2014) that have less activity toward class I and class 
II PI3Ks. However, as PI3P generation by VPS34 is required for other membrane 
trafficking processes, targeting other autophagy essential genes such as ULK1 may 
result in more specific autophagy inhibitors. To this end, several attempts to develop 
small molecule inhibitors against ULK1 are already underway (Lazarus et al., 2015; 
Petherick et al., 2015; Rosenberg et al., 2015). The crystal structure of human ULK1 
kinase domain by Shokat and colleagues would certainly be a useful tool in the 
optimization of new compounds (Lazarus et al., 2015). 
 
The relationship between autophagy and cancer is complex and has been reported to 
be both context and cancer dependent. In this study, I demonstrate that “autophagy 
addicted” PDAC cell line 8988T requires both PP2A activity and the ULK1 complex 
to maintain high basal levels of autophagy, rapid proliferation, and sustained 
anchorage-independent growth in the absence of mTOR inactivation. While the 
mechanism driving phosphatase activation is unclear, I observed a correlation of low 
Alpha4 levels in 8988T and high B55α levels in BxPC3. It would be interesting to see 
if these proteins together with ULK1 could be used as predictive markers to identify 
cancers that would be susceptible to ULK1 inhibition.  
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